Instructions for Authors — Applied Intelligence
Source: https://link.springer.com/journal/10489/submission-guidelines
Submission guidelines
Contents
Instructions for Authors- Manuscript Submission Title Page Text Author tools for article preparation LaTeX and Online Submission References Tables Artwork and Illustrations Guidelines Supplementary Information (SI)) Research Data Policy and Data Availability Statements Editing Services Ethical Responsibilities of Authors Authorship principles Additional Information for Changes to authorship Compliance with Ethical Standards Competing Interests After acceptance Open Choice
Open access publishing Mistakes to avoid during manuscript preparation
Instructions for Authors
Manuscript Submission
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.
Source Files
Please ensure you provide all relevant editable source files at every submission and revision. Failing to submit a complete set of editable source files will result in your article not being considered for review. For your manuscript text please always submit in common word processing formats such as .docx or LaTeX.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
- The name(s) of the author(s)
- The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
- A clear indication and an active e-mail address of the corresponding author
- If available, the 16-digit ORCIDof the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Large Language Models (LLMs), such as ChatGPT, do not currently satisfy our authorship criteria. Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript. The use of an LLM (or other AI-tool) for "AI assisted copy editing" purposes does not need to be declared. In this context, we define the term "AI assisted copy editing" as AI-assisted improvements to human-generated texts for readability and style, and to ensure that the texts are free of errors in grammar, spelling, punctuation and tone. These AI-assisted improvements may include wording and formatting changes to the texts, but do not include generative editorial work and autonomous content creation. In all cases, there must be human accountability for the final version of the text and agreement from the authors that the edits reflect their original work.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
- Trial registration number and date of registration for prospectively registered trials
- Trial registration number and date of registration, followed by “retrospectively registered”, for retrospectively registered trials
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.
Statements and Declarations
The following statements should be included under the heading "Statements and Declarations" for inclusion in the published paper. Please note that submissions that do not include relevant declarations will be returned as incomplete.
- Competing Interests:Authors are required to disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication. Please refer to “Competing Interests and Funding” below for more information on how to complete this section.
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Text
For LaTeX submissions we encourage authors to use the Springer Nature LaTeX template when preparing a submission.
Please ensure you provide all relevant editable source files at every submission and revision.
Text Formatting
Manuscripts should be submitted in LaTeX. We recommend using Springer Nature’s LaTeX template. The submission should include the original source (including all style files and figures) and a PDF version of the compiled output.
Headings
Please use the decimal system of headings with no more than three levels.
Abbreviations
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.
Author tools for article preparation
Manuscripts should be submitted in LaTeX. Please use Springer’s LaTeX macro package and choose the formatting option “smallcondensed”.
The submission should include the original source (including all style files and figures) and a PDF version of the compiled output.
LaTeX and Online Submission
All source files you upload in the online submission system will be automatically compiled into a single PDF file to be approved by you at the end of the submission process. While the compiled PDF will be used for peer-review purposes, your uploaded source files will be transferred to the publisher for publication upon acceptance.
Please do not use subfolders for your LaTeX submission, e.g. for figures or bibliographic files. Further tips for uploading and compiling your LaTeX submission can be found on the Springer Nature LaTeX Support hub and https://www.editorialmanager.com/robohelp/17.0/LaTeX_Resources.htm?rhhlterm=latex.
References
Citation
Reference citations in the text should be identified by numbers in square brackets. Some examples:
-
Negotiation research spans many disciplines [3].
-
This result was later contradicted by Becker and Seligman [5].
-
This effect has been widely studied [1-3, 7].
Reference list
The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.
The entries in the list should be numbered consecutively.
If available, please always include DOIs as full DOI links in your reference list (e.g. “https://doi.org/abc”).
- Journal articleGamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731-738. https://doi.org/10.1007/s00421-008-0955-8 Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted: Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329
- Article by DOI Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med. https://doi.org/10.1007/s001090000086
- BookSouth J, Blass B (2001) The future of modern genomics. Blackwell, London
- Book chapterBrown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp 230-257
- Online documentCartwright J (2007) Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2007
- DissertationTrent JW (1975) Experimental acute renal failure. Dissertation, University of California
Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see
If you are unsure, please use the full journal title.
Authors preparing their manuscript in LaTeX can use the bibliography style file sn-basic.bst which is included in the Springer Nature Article Template.
Tables
- All tables are to be numbered using Arabic numerals.
- Tables should always be cited in text in consecutive numerical order.
- For each table, please supply a table caption (title) explaining the components of the table.
- Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
- Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.
Artwork and Illustrations Guidelines
Electronic Figure Submission
- Supply all figures electronically.
- Indicate what graphics program was used to create the artwork.
- For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.
- Vector graphics containing fonts must have the fonts embedded in the files.
- Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
Line Art
- Definition: Black and white graphic with no shading.
- Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
- All lines should be at least 0.1 mm (0.3 pt) wide.
- Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
- Vector graphics containing fonts must have the fonts embedded in the files.
Halftone Art
- Definition: Photographs, drawings, or paintings with fine shading, etc.
- If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
- Halftones should have a minimum resolution of 300 dpi.
Combination Art
- Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
- Combination artwork should have a minimum resolution of 600 dpi.
Color Art
- Color art is free of charge for online publication.
- If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
- If the figures will be printed in black and white, do not refer to color in the captions.
- Color illustrations should be submitted as RGB (8 bits per channel).
Figure Lettering
- To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
- Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
- Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
- Avoid effects such as shading, outline letters, etc.
- Do not include titles or captions within your illustrations.
Figure Numbering
- All figures are to be numbered using Arabic numerals.
- Figures should always be cited in text in consecutive numerical order.
- Figure parts should be denoted by lowercase letters (a, b, c, etc.).
- If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures,"A1, A2, A3, etc." Figures in online appendices [Supplementary Information (SI)] should, however, be numbered separately.
Figure Captions
- Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
- Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
- No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
- Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
- Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.
Figure Placement and Size
- Figures should be submitted within the body of the text. Only if the file size of the manuscript causes problems in uploading it, the large figures should be submitted separately from the text.
- When preparing your figures, size figures to fit in the column width.
- For large-sized journals the figures should be 84 mm (for double-column text areas), or 174 mm (for single-column text areas) wide and not higher than 234 mm.
- For small-sized journals, the figures should be 119 mm wide and not higher than 195 mm.
If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.
Accessibility
In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
- All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
- Patterns are used instead of or in addition to colors for conveying information (colorblind users would then be able to distinguish the visual elements)
- Any figure lettering has a contrast ratio of at least 4.5:1
Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein.
Supplementary Information (SI)
Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.
Before submitting research datasets as Supplementary Information, authors should read the journal’s Research data policy. We encourage research data to be archived in data repositories wherever possible.
Submission
- Supply all supplementary material in standard file formats.
- Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
- To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.
Audio, Video, and Animations
- Aspect ratio: 16:9 or 4:3
- Maximum file size: 2 GB
- Minimum video duration: 1 sec
- Supported file formats: avi, wmv, mp4, mov, m2p, mp2, mpg, mpeg, flv, mxf, mts, m4v, 3gp
Text and Presentations
- Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
- A collection of figures may also be combined in a PDF file.
Spreadsheets
- Spreadsheets should be submitted as .csv or .xlsx files (MS Excel).
Specialized Formats
- Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.
Collecting Multiple Files
- It is possible to collect multiple files in a .zip or .gz file.
Numbering
- If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
- Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
- Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.
Captions
- For each supplementary material, please supply a concise caption describing the content of the file.
Processing of supplementary files
- Supplementary Information (SI) will be published as received from the author without any conversion, editing, or reformatting.
In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that
- The manuscript contains a descriptive caption for each supplementary material
- Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)
Research Data Policy and Data Availability Statements
This journal follows Springer Nature research data policy. Sharing of all relevant research data is strongly encouraged and authors must add a Data Availability Statement to original research articles.
Research data includes a wide range of types, including spreadsheets, images, textual extracts, archival documents, video or audio, interview notes or any specialist formats generated during research.
Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here.
If it is not possible to share research data publicly, for instance when individual privacy could be compromised, this statement should describe how data can be accessed and any conditions for reuse. Participant consent should be obtained and documented prior to data collection. See our guidance on sensitive data for more information.
When creating a data availability statement, authors are encouraged to consider the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article.
Further guidance on writing a data availability statement, including examples, is available at:
Data repositories
Authors are strongly encouraged to deposit their supporting data in a publicly available repository. Sharing your data in a repository promotes the integrity, discovery and reuse of your research, making it easier for the research community to build on and credit your work.
See our data repository guidance for information on finding a suitable repository.
We recommend the use of discipline-specific repositories where available. For a number of data types, submission to specific public repositories is mandatory.
See our list of mandated data types.
The journal encourages making research data available under open licences that permit reuse. The journal does not enforce use of particular licences in third party repositories. You should ensure you have necessary rights to share any data that you deposit in a repository.
Data citation
The journal recommends that authors cite any publicly available data on which the conclusions of the paper rely. This includes data the authors are sharing alongside their publication and any secondary data the authors have reused. Data citations should include a persistent identifier (such as a DOI), should be included in the reference list using the minimum information recommended by DataCite (Dataset Creator, Dataset Title, Publisher [repository], Publication Year, Identifier [e.g. DOI, Handle, Accession or ARK]) and follow journal style.
See our further guidance on citing datasets.
Research data and peer review
If the journal that you are submitting to uses double-anonymous peer review and you are providing reviewers with access to your data (for example via a repository link, supplementary information or data on request), it is strongly suggested that the authorship in the data is also anonymised. There are data repositories that can assist with this and/or will create a link to mask the authorship of your data.
Support with research data policy
Authors who need help understanding our data sharing policy, finding a suitable data repository, or organising and sharing research data can consult our Research Data Helpdesk for guidance.
See our FAQ page for more information on Springer Nature's research data policy.
Editing Services
English
How can you help improve your manuscript for publication?
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light. The experts at Springer Nature Author Services can help you with manuscript preparation—including English language editing, developmental comments, manuscript formatting, figure preparation, translation, and more.
You can also use our free Grammar Check tool for an evaluation of your work.
Please note that using these tools, or any other service, is not a requirement for publication, nor does it imply or guarantee that editors will accept the article, or even select it for peer review.
Chinese (中文)
您怎么做才有助于改进您的稿件以便顺利发表?
如果在结构精巧的稿件中用精心组织的英语展示您的作品,就能最大限度地让编辑和审稿人理解并公正评估您的作品。许多研究人员发现,获得一些独立支持有助于他们以尽可能美好的方式展示他们的成果。Springer Nature Author Services 的专家可帮助您准备稿件,具体包括润色英语表述、添加有见地的注释、为稿件排版、设计图表、翻译等。
您还可以使用我们的免费语法检查工具来评估您的作品。
请注意,使用这些工具或任何其他服务不是发表前必须满足的要求,也不暗示或保证相关文章定会被编辑接受(甚至未必会被选送同行评审)。
Japanese (日本語)
発表に備えて、論文を改善するにはどうすればよいでしょうか?
内容が適切に組み立てられ、質の高い英語で書かれた論文を投稿すれば、編集者や査読者が論文を理解し、公正に評価するための最善の機会となります。多くの研究者は、個別のサポートを受けることで、研究結果を可能な限り最高の形で発表できると思っています。Springer Nature Author Servicesのエキスパートが、英文の編集、建設的な提言、論文の書式、図の調整、翻訳など、論文の作成をサポートいたします。
原稿の評価に、無料の文法チェックツールもご利用いただけます。
これらのツールや他のサービスをご利用いただくことは、論文を掲載するための要件ではありません。また、編集者が論文を受理したり、査読に選定したりすることを示唆または保証するものではないことにご注意ください。
Korean (한국어)
게재를 위해 원고를 개선하려면 어떻게 해야 할까요?
여러분의 작품을 체계적인 원고로 발표하는 것은 편집자와 심사자가 여러분의 연구를 이해하고 공정하게 평가할 수 있는 최선의 기회를 제공합니다. 많은 연구자들은 어느 정도 독립적인 지원을 받는 것이 가능한 한 최선의 방법으로 자신의 결과를 발표하는 데 도움이 된다고 합니다. Springer Nature Author Services 전문가들은 영어 편집, 발전적인 논평, 원고 서식 지정, 그림 준비, 번역 등과 같은 원고 준비를 도와드릴 수 있습니다.
또한 당사의 무료 문법 검사도구를 사용하여 여러분의 연구를 평가할 수 있습니다.
이러한 도구 또는 기타 서비스를 사용하는 것은 게재를 위한 필수 요구사항이 아니며, 편집자가 해당 논문을 수락하거나 피어 리뷰에 해당 논문을 선택한다는 것을 암시하거나 보장하지는 않습니다.
Ethical Responsibilities of Authors
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:
- The manuscript should not be submitted to more than one journal for simultaneous consideration.
- The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
- A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
- Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
- Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.
- No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
- Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
- Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged.
- Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
- Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
- Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.
*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
- If the manuscript is still under consideration, it may be rejected and returned to the author.
- If the article has already been published online, depending on the nature and severity of the infraction: - an erratum/correction may be placed with the article - an expression of concern may be placed with the article - or in severe cases retraction of the article may occur.
The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
- The author’s institution may be informed
- A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
Fundamental errors
Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.
Suggesting / excluding reviewers
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.
Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.
Authorship clarified
The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:
All authors whose names appear on the submission
1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
2) drafted the work or revised it critically for important intellectual content;
3) approved the version to be published; and
4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
- Based on/adapted from:
[ICMJE, Defining the Role of Authors and Contributors,
](http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html)
Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).
The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.
Data transparency
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.
The Corresponding Author is responsible for the following requirements:
- ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
- managing all communication between the Journal and all co-authors, before and after publication;*
- providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
-
making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).
-
The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.
Author contributions
In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.
Examples of such statement(s) are shown below:
• Free text:
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and investigation: [full name], …; Writing - original draft preparation: [full name, …]; Writing - review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full name], …; Supervision: [full name],….
For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.
For articles that are based primarily on the student’s dissertation or thesis, it is recommended that the student is usually listed as principal author:
Affiliation
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.
- Please note that author names will be published exactly as they appear on the accepted submission!
Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.
Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.
Author identification
Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.
Authorship issues or disputes
In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.
Confidentiality
Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.
Additional Information for Changes to authorship
This journal strongly discourages authorship change after submission. Any authorship change will involve approval from co-authors, the editor handling the submission and the editor-in-chief. A request for authorship change should take the form of a formal letter to the editor-in-chief stating exactly what parts require an authorship change and including details why there is a change that deviates from the original declaration of authorship.
Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.
Authors should include the following statements (if applicable) in a separate section entitled “Compliance with Ethical Standards” when submitting a paper:
- Disclosure of potential conflicts of interest
- Research involving Human Participants and/or Animals
- Informed consent
Please note that standards could vary slightly per journal dependent on their peer review policies (i.e. single or double blind peer review) as well as per journal subject discipline. Before submitting your article check the instructions following this section carefully.
The corresponding author should be prepared to collect documentation of compliance with ethical standards and send if requested during peer review or after publication.
The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines. The author will be held responsible for false statements or failure to fulfill the above-mentioned guidelines.
Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.
Editorial Board Members and Editors are required to declare any competing interests and may be excluded from the peer review process if a competing interest exists. In addition, they should exclude themselves from handling manuscripts in cases where there is a competing interest. This may include – but is not limited to – having previously published with one or more of the authors, and sharing the same institution as one or more of the authors. Where an Editor or Editorial Board Member is on the author list we recommend they declare this in the competing interests section on the submitted manuscript. If they are an author or have any other competing interest regarding a specific manuscript, another Editor or member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. These submissions are subject to the exact same review process as any other manuscript. Editorial Board Members are welcome to submit papers to the journal. These submissions are not given any priority over other manuscripts, and Editorial Board Member status has no bearing on editorial consideration.
Interests that should be considered and disclosed but are not limited to the following:
Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.
Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).
Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.
It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: "Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published."
Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.
Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement. Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief.
Please note that, in addition to the above requirements, funding information (given that funding is a potential competing interest (as mentioned above)) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Funding’ and/or ‘Competing interests’. Other declarations include Ethics approval, Consent, Data, Material and/or Code availability and Authors’ contribution statements.
Please see the various examples of wording below and revise/customize the sample statements according to your own needs.
When all authors have the same (or no) conflicts and/or funding it is sufficient to use one blanket statement.
Examples of statements to be used when funding has been received:
- Partial financial support was received from [...]
- The research leading to these results received funding from […] under Grant Agreement No[…].
- This study was funded by […]
- This work was supported by […] (Grant numbers […] and […]
Examples of statements to be used when there is no funding:
- The authors did not receive support from any organization for the submitted work.
- No funding was received to assist with the preparation of this manuscript.
- No funding was received for conducting this study.
- No funds, grants, or other support was received.
Examples of statements to be used when there are interests to declare:
- Financial interests:Author A has received research support from Company A. Author B has received a speaker honorarium from Company W and owns stock in Company X. Author C is consultant to company Y.- Non-financial interests:Author C is an unpaid member of committee Z.
- Financial interests:The authors declare they have no financial interests.- Non-financial interests:Author A is on the board of directors of Y and receives no compensation as member of the board of directors.
- Financial interests:Author A received a speaking fee from Y for Z. Author B receives a salary from association X. X where s/he is the Executive Director.- Non-financial interests:none.
- Financial interests:Author A and B declare they have no financial interests. Author C has received speaker and consultant honoraria from Company M and Company N. Dr. C has received speaker honorarium and research funding from Company M and Company O. Author D has received travel support from Company O.- Non-financial interests:Author D has served on advisory boards for Company M, Company N and Company O.
Examples of statements to be used when authors have nothing to declare:
- The authors have no relevant financial or non-financial interests to disclose.
- The authors have no competing interests to declare that are relevant to the content of this article.
- All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
- The authors have no financial or proprietary interests in any material discussed in this article.
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
After acceptance
Upon acceptance, your article will be exported to Production to undergo typesetting. Shortly after this you will receive two e-mails. One contains a request to confirm your affiliation, choose the publishing model for your article, as well as to arrange rights and payment of any associated publication cost. A second e-mail containing a link to your article’s proofs will be sent once typesetting is completed.
Article publishing agreement
Depending on the ownership of the journal and its policies, you will either grant the Publisher an exclusive licence to publish the article or will be asked to transfer copyright of the article to the Publisher.
Offprints
Offprints can be ordered by the corresponding author.
Color illustrations
Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs.
Proof reading
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
Online First
The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.
Open Choice
Open Choice allows you to publish open access in more than 1850 Springer Nature journals, making your research more visible and accessible immediately on publication.
Article processing charges (APCs) vary by journal – view the full list
Benefits:
- Increased researcher engagement: Open Choice enables access by anyone with an internet connection, immediately on publication.
- Higher visibility and impact: In Springer hybrid journals, OA articles are accessed 4 times more often on average, and cited 1.7 more times on average*.
- Easy compliance with funder and institutional mandates: Many funders require open access publishing, and some take compliance into account when assessing future grant applications.
It is easy to find funding to support open access – please see our funding and support pages for more information.
*) Within the first three years of publication. Springer Nature hybrid journal OA impact analysis, 2018.
Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide.
Open access publishing
To find out more about publishing your work Open Access in Applied Intelligence, including information on fees, funding and licences, visit our Open access publishing page.
Get your manuscript ready for journal editors
Follow our checklist to avoid common mistakes and get your manuscript to journal editors faster
After submission
- Submission received
- Technical check
- Editor review
- Peer review
- Final decision
- Payments and rights
- Publication
Journal policies
Overview
Springer journals will be guided by COPE guidelines, however the journals will continue to make independent decisions based on our existing policies and principles.
Communicate with respect
At Springer Nature we believe that only through relationships based upon mutual respect can we build trust and deliver quality publishing products and services to the communities we serve. Our staff are expected to behave professionally and respectfully at all times when engaging with authors, reviewers and readers. Likewise, we expect the same standards of behavior from the academic community and the public in their interactions with our staff. We do not tolerate aggressive behavior, or any form of harassment, bullying or discrimination directed against Springer Nature staff. We reserve the right to bring serious cases to the attention of employers or local authorities, if needed, and may refuse to interact, or do business, with individuals who repeatedly or seriously violate this policy.
Authorship principles
Authorship definition
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere.
Authorship clarified
Springer Nature assumes that all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.
- made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;
- drafted the work or revised it critically for important intellectual content;
- approved the version to be published; and
- agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Springer journals encourage collaboration with colleagues in the locations where the research is conducted and expect their inclusion as co-authors when they fulfil all authorship criteria described above. Contributors who do not meet all criteria for authorship should be listed in the Acknowledgements section.
Based on/adapted from:
a. ICMJE, Defining the Role of Authors and Contributors, http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
b. Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication, McNutt at all, PNAS February 27, 2018 https://doi.org/10.1073/pnas.1715374115
Disclosures and declarations
Data transparency
Role of the corresponding author
Author contributions
Please check the Instructions for Authors of the Journal that you are submitting to for specific instructions regarding contribution statements.
Springer portfolio journals encourage transparency by publishing author contribution statements. Authors are required to include a statement of responsibility in the manuscript, including review-type articles, that specifies the contribution of every author. The level of detail varies; some disciplines produce manuscripts that comprise discrete efforts readily articulated in detail, whereas other fields operate as group efforts at all stages. Author contribution statements are included in the published paper. This Editorial describes the policy in more detail.
Springer journals also allow one set of co-authors to be specified as having contributed equally to the work and one set of co-authors to be specified as having jointly supervised the work. Other equal contributions are best described in author contribution statements.
Affiliation
Changes to authorship
Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Any changes to the author list after submission, such as a change in the order of the authors or the deletion or addition of authors, must be approved by every author. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not permitted after acceptance of a manuscript.
Please note that author names will be published exactly as they appear on the accepted submission.
Author name change
An author who has changed their name for reasons such as gender transition or religious conversion may request for their name, pronouns and other relevant biographical information to be corrected on papers published prior to the change. The author can choose for this correction to happen silently, in which case there will be no note flagging the change on either the pdf or the html of the paper, or alternatively they may do so by a formal public Author Correction.
For authors who’ve changed their name and wish to correct it on their published works, please see SNCS Contact Form: Inclusive Name Change Policy: Springer Nature Support.
Author identification
Authors are strongly recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.
Deceased or incapacitated authors
Confidentiality
Authorship issues or disputes
Competing interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.
Interests that should be considered and disclosed include, but are not limited, to the following:
Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.
Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.
Please note that, in addition to the above requirements, funding information (given that funding is a potential conflict of interest (as mentioned above)) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.
Summary of requirements
The above should be summarized in a statement and included in a section entitled “Declarations” before the reference list. Other declarations include Funding, Conflicts of interest/competing interests, Ethics approval, Consent, Data and/or Code availability and Authors’ contribution statements.
Should the information already be mentioned somewhere else in the manuscript, for example under Methods & Materials, please make sure to repeat that information on this page.
Provide “Funding” as a heading (see template)
In case of no funding:
Provide “Conflicts of interest/Competing interests” as a heading (see template)
- Financial interests:Author A has received research support from Company A. Author B has received a speaker honorarium from Company Wand owns stock in Company X. Author C is consultant to company Y.
- Non-financial interests:Author C is an unpaid member of committee Z.
- Financial interests:The authors declare they have no financial interests.
- Non-financial interests:Author A is on the board of directors of Y and receives no compensation as member of the board of directors.
- Financial interests:Author A received a speaking fee from Y for Z. Author B receives a salary from association X. X where s/he is the Executive Director.
- Non-financial interests:none.
- Financial interests:Author A and B declare they have no financial interests. Author C has received speaker and consultant honoraria from Company M and Company N. Dr. C has received speaker honorarium and research funding from Company M and Company O. Author D has received travel support from Company O.
- Non-financial interests:Author D has served on advisory boards for Company M, Company N and Company O.
When authors have nothing to declare the following statement may be used:
- The authors have no relevant financial or non-financial interests to disclose.
- The authors have no conflicts of interest to declare that are relevant to the content of this article.
- All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
- The authors have no financial or proprietary interests in any material discussed in this article.
Ethical responsibilities of authors
Springer Nature is committed to upholding the integrity of the scientific record.
The manuscript should not be submitted to more than one publication for simultaneous consideration. The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’). A single study should not be split up into several parts to increase the quantity of submissions and submitted to various publications or to one publication over time (i.e. ‘salami-slicing/publishing’). Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers. Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.
Important note: the journal may use software to screen for plagiarism.
Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged. Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person. Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript. See also [Authorship principles.]
All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
If there is suspicion of misbehaviour or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
The reason will be given in the published erratum/correction, editorial expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
The author’s institution may be informed. A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.
Fundamental errors
Suggesting / excluding reviewers
Citations
Authors are responsible for identifying and documenting relevant citations to support their work.
Unethical practice in creating manuscript citations is a breach of our Act with Integrity policy [Journals =Editorial policies Books =Book Publishing Policies] and may result in the manuscript being rejected for publication or retracted post-publication. This may also be reported to authors’ institutions. Unethical practice includes:
- Citation manipulation (e.g. excessive self-citation, gratuitous and unnecessary citation of content published in the journal/book series to which the manuscript has been submitted).
- Unreliable citations (e.g. irrelevant citations, non-existent/hallucinated references generated by an artificial intelligence (AI) tool, improper citations to retracted works).
Any attempts by peer-reviewers, editors or other parties to encourage unethical practices (including but not limited to requests for irrelevant or unnecessary citations) should be reported by authors to the publisher.
When preparing a manuscript, authors should:
- Use a citation to support any statement in the manuscript that relies on external sources of information (i.e. not the authors' own new ideas or findings or general knowledge).
- Have read all cited sources and ensured that they are accurate and relevant to the statement made in the manuscript.
- Cite the original work and not a derivation of the work (except where necessary) e.g. review article that cites an original work.
- Aim to include citations from a diverse range of sources, and should avoid citing research from a single source e.g. from their peers, their institution, works solely from one country, etc.
- Avoid using excessive number of citations to support one point (except where necessary).
- Cite sources that have undergone peer review where possible.
- Avoid citing advertisements or advertorial material (e.g. promotional and marketing materials) where possible.
- Carefully review citations following any use of AI in manuscript preparation, including use of AI for copy-editing and translation, as the AI tool may make changes to the citation text. Use of AI to generate citations can result in non-existent/hallucinated citations.
- Include the Digital Object Identifier (DOI) of the citation’s source where possible.
Preprint sharing
Springer Nature journals encourage posting of preprints of primary research manuscripts on preprint servers of the authors’ choice, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms.
Preprints are defined as an author’s version of a research manuscript prior to formal peer review at a journal, which is deposited on a public server (as described in Preprints for the life sciences. Science 352, 899–901; 2016); preprints may be posted at any time during the peer review process. Posting of preprints is not considered prior publication and will not jeopardize consideration at Springer Nature journals.
Manuscripts posted on preprint servers will not be taken into account when determining the advance provided by a study under consideration at a Springer Nature journal.
Springer Nature has partnered with Research Square (Springer Nature has a majority interest in Research Square) to provide In Review, a journal-integrated solution for preprint sharing, supporting authors across all the communities we serve to share their research early. Authors submitting to some Springer Nature journals are also able to publicly share information regarding their peer review through In Review. General information about In Review at Springer Nature and the Research Square preprint platform can be found here and here.
Our policy on posting, licensing, citation of preprints and communications with the media about preprints of primary research manuscripts is summarized below.
Authors should disclose details of preprint posting, including DOI and licensing terms, upon submission of the manuscript or at any other point during consideration at a Springer Nature journal. Once the preprint is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.
Authors may choose any license of their choice for the preprint including Creative Commons licenses. The type of CC-license chosen will affect how the preprint may be shared and reused. More information to help guide licensing choices can be found in these resource documents developed by an ASAPbio licensing taskforce.
Preprints may be cited in the reference list of articles under consideration at Springer Nature journals as shown below:
Babichev, S. A., Ries, J. & Lvovsky, A. I. Quantum scissors: teleportation of single-mode optical states by means of a nonlocal single photon. Preprint at http://arxiv.org/abs/quant-ph/0208066 (2002).
Authors posting preprints are asked to respect our policy on communications with the media. Researchers may respond to requests from the media in response to a preprint or conference presentation by providing explanation or clarification of the work, or information about its context. In these circumstances, media coverage will not hinder editorial handling of the submission. Researchers should be aware however that such coverage may reduce or pre-empt coverage by other media at the time of publication. We also advise that researchers approached by reporters in response to a preprint make it clear that the paper has not yet undergone peer review, that the findings are provisional and that the conclusions may change. More information to help guide responsible communication of research reported in preprints can be found in these resource documents developed by the ASAPbio Preprints in the Public Eye project.
Information about our self-archiving policies and release of Author’s Accepted Manuscript may be found here.
Corrections, retractions and matters arising
Corrections and retractions
Rarely, it may be necessary to publish corrections to, or retractions of, articles published in journals, to maintain the integrity of the academic record.
Corrections to, or retractions of, published articles will be made by publishing a Correction or a Retraction note bidirectionally linked to the original article. Any alterations to the original article will be described in the note. The original article remains in the public domain and the subsequent Correction or Retraction will be widely indexed. In the exceptional event that material is considered to infringe certain rights or is defamatory, we may have to remove that material from our site and archive sites.
Authors, readers or organizations who become aware of errors or ethics issues in a published article are encouraged to contact the individual journal in the first instance via the contact details available on the journal website. All reports will be considered by the Editors; additional expert advice may be sought when deciding on the most appropriate course of action. The Springer Nature Research Integrity Group provides support to Editors in addressing publication ethics issues in a COPE (Committee on Publication Ethics)-compliant manner.
Corrections
Errors in published articles that affect the accuracy of the article, but do not substantially invalidate the conclusion, will, at the Editor(s)’ discretion, be corrected via publication of a Correction that is indexed and bidirectionally linked to the original article.
For authors who’ve changed their name and wish to correct it on their published works, please see SNCS Contact Form: Inclusive Name Change Policy : Springer Nature Support.
Retractions
On rare occasions, when the interpretation or conclusion of an article is substantially undermined, it may be necessary for published articles to be retracted. Editorial decisions to retract are based on the reliability of the article and whether the Editor still has confidence in the interpretation of the work and/or conclusions being presented. Springer will follow the COPE guidelines in such cases. Retractions are designed to be a neutral tool to correct the literature and should not be viewed as punitive. Retraction notices are indexed and bidirectionally linked to the original article. The original article is watermarked as retracted, and the title is amended with the prefix “Retracted article:”
Editorial expressions of concern and editor’s notes
Editor's Note: An Editor's Note is a notification alerting readers if the journal has initiated an inquiry in response to concerns raised about a published article. It is an online-only update, made only to the HTML version of record of the published article. It is not indexed.
Editorial Expression of Concern: An Editorial Expression of Concern is a statement from the editors alerting readers to serious concerns affecting the integrity of the published paper. EEoCs are published online and are bidirectionally linked to the published paper. They receive a DOI and are indexed in major scholarly databases such as PubMed, Web of Science and Scopus. EEoCs may be an interim measure or may be final.
Publishing an Editor’s Note or EEoC is recommended by the Committee on Publication Ethics (COPE) as a means of keeping readers updated while a potentially lengthy research integrity investigation is underway. Editor’s Notes and EEoCs are typically but not always superseded by publishing another amendment―such as a correction or retraction―once the investigation is complete.
Removal of published content
In exceptional circumstances, Springer Nature reserves the right to remove an article, chapter, book or other content from Springer Nature’s online platforms. Such action may be taken when (i) Springer Nature has been advised that content is defamatory, infringes a third party’s intellectual property right, right to privacy, or other legal right, or is otherwise unlawful; (ii) a court or government order has been issued, or is likely to be issued, requiring removal of such content; (iii) content, if acted upon, would pose an immediate and serious risk to health. Removal may be temporary or permanent. Bibliographic metadata (e.g. title and authors) will be retained and will be accompanied by a statement explaining why the content has been removed.
Matters arising
Springer Nature journals recognise the importance of post-publication commentary on published research as necessary to advancing scientific discourse. Formal post-publication commentary on published papers can include challenges, clarifications or, in some cases, replication of the published work. These comments should reflect the knowledge available at the time the original paper was written, rather than later scientific developments.
At the discretion of the Editor, and dependant on the nature of the piece, post-publication comment or discussion will be evaluated, peer-reviewed and after peer review may be published online as Matters Arising. Authors of the original work will be invited to reply and this may also be published alongside the post-publication commentary.
Appeals and complaints
Policy and process
The below procedure applies to appeals to editorial decisions, complaints about failure of processes such as long delays in handling papers and complaints about publication ethics. The complaint should in first instance be handled by the Editor-in-Chief(s) responsible for the journal and/or the Editor who handled the paper. If they are the subject of the complaint please approach the in-house publishing contact. (Please check the contacts page on the journal homepage. If no publishing contact is identified send the query to [email protected]).
Complaint about scientific content, e.g. an appeal against rejection
The Editor-in-Chief or Handling Editor considers the authors’ argument, the reviewer reports and decides whether
- The decision to reject should stand;
- Another independent opinion is required
- The appeal should be considered.
The complainant is informed of the decision with an explanation if appropriate. Decisions on appeals are final, and new submissions take priority over appeals.
Complaint about processes, e.g. time taken to review
The Editor-in-Chief together with the Handling Editor (where appropriate) and/or in-house contact (where appropriate) will investigate the matter. The complainant will be given appropriate feedback. Feedback is provided to relevant stakeholders to improve processes and procedures.
Complaint about publication ethics, e.g., researcher's author's, or reviewer's conduct
The Editor-in-Chief or Handling Editor follows guidelines published by the Committee on Publication Ethics. The Editor-in-Chief or Handling Editor may ask the publisher via their in-house contact for advice on difficult or complicated cases. The Editor-in-Chief or Handling Editor decides on a course of action and provides feedback to the complainant. If the complainant remains dissatisfied with the handling of their complaint, he or she can submit the complaint to the Committee on Publication Ethics. More information can be found here.
Predatory journals and references
When using sources for your research, please be aware that material could have been published in questionable, scholarly, usually Open Access journals. These “predatory” journals include the variety that seek to attract potential authors with flattering spam e-mails assuring rapid publication on the basis of the Journal’s highly esteemed reputation in the field. Too often, these journals have exactly the same or very similar names to those of well-established journals. Springer Nature recommends authors to assess carefully whether an article published by a “predatory” journal should be referenced. Please note that several abstracting & indexing services, including Clarivate Analytics, are taking ethical publication seriously by examining the content, practices, and websites of these “predatory” journals.
If you would like to learn more about learned (Open Access) publishers and publications please visit the following links:
Artificial intelligence (AI)
Springer Nature is monitoring ongoing developments in this area closely and will review (and update) these policies as appropriate.
AI authorship
Large Language Models (LLMs), such as ChatGPT, do not currently satisfy our authorship criteria. Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript. The use of an LLM (or other AI-tool) for “AI assisted copy editing” purposes does not need to be declared. In this context, we define the term "AI assisted copy editing" as AI-assisted improvements to human-generated texts for readability and style, and to ensure that the texts are free of errors in grammar, spelling, punctuation and tone. These AI-assisted improvements may include wording and formatting changes to the texts, but do not include generative editorial work and autonomous content creation. In all cases, there must be human accountability for the final version of the text and agreement from the authors that the edits reflect their original work.
Generative AI images
The fast-moving area of generative AI image creation has resulted in novel legal copyright and research integrity issues. As publishers, we strictly follow existing copyright law and best practices regarding publication ethics. While legal issues relating to AI-generated images and videos remain broadly unresolved, Springer Nature journals are unable to permit its use for publication.
Exceptions:
- Images/art obtained from agencies that we have contractual relationships with that have created images in a legally acceptable manner.
- Images and videos that are directly referenced in a piece that is specifically about AI and such cases will be reviewed on a case-by-case basis.
- The use of generative AI tools developed with specific sets of underlying scientific data that can be attributed, checked and verified for accuracy, provided that ethics, copyright and terms of use restrictions are adhered to.
*All exceptions must be labelled clearly as generated by AI within the image field.
As we expect things to develop rapidly in this field in the near future, we will review this policy regularly and adapt it if necessary.
NOTE: Examples of image types covered by this policy include: video and animation, including video stills; photography; illustration such as scientific diagrams, photo-illustrations and other collages, and editorial illustrations such as drawings, cartoons or other 2D or 3D visual representations. Not included in this policy are text-based and numerical display items, such as: tables, flow charts and other simple graphs that do not contain images. Please note that not all AI tools are generative. The use of non-generative machine learning tools to manipulate, combine or enhance existing images or figures should be disclosed in the relevant caption upon submission to allow a case-by-case review.
AI use by peer reviewers
Peer reviewers play a vital role in scientific publishing. Their expert evaluations and recommendations guide editors in their decisions and ensure that published research is valid, rigorous, and credible. Editors select peer reviewers primarily because of their in-depth knowledge of the subject matter or methods of the work they are asked to evaluate. This expertise is invaluable and irreplaceable. Peer reviewers are accountable for the accuracy and views expressed in their reports, and the peer review process operates on a principle of mutual trust between authors, reviewers and editors. Despite rapid progress, generative AI tools have considerable limitations: they can lack up-to-date knowledge and may produce nonsensical, biased or false information. Manuscripts may also include sensitive or proprietary information that should not be shared outside the peer review process. For these reasons we ask that, while Springer Nature explores providing our peer reviewers with access to safe AI tools, peer reviewers do not upload manuscripts into generative AI tools.
If any part of the evaluation of the claims made in the manuscript was in any way supported by an AI tool, we ask peer reviewers to declare the use of such tools transparently in the peer review report.
Ethics and biosecurity
Informed consent
All individuals have individual rights that are not to be infringed. Individual participants in studies have, for example, the right to decide what happens to the (identifiable) personal data gathered, to what they have said during a study or an interview, as well as to any photograph that was taken. This is especially true concerning images of vulnerable people (e.g. minors, patients, refugees, etc) or the use of images in sensitive contexts. In many instances authors will need to secure written consent before including images.
Identifying details (names, dates of birth, identity numbers, biometrical characteristics (such as facial features, fingerprint, writing style, voice pattern, DNA or other distinguishing characteristic) and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scholarly purposes and the participant (or parent/guardian if the participant is a minor or incapable or legal representative) gave written informed consent for publication. Complete anonymity is difficult to achieve in some cases. Detailed descriptions of individual participants, whether of their whole bodies or of body sections, may lead to disclosure of their identity. Under certain circumstances consent is not required as long as information is anonymized and the submission does not include images that may identify the person.
Informed consent for publication should be obtained if there is any doubt. For example, masking the eye region in photographs of participants is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors should provide assurance that alterations do not distort meaning.
Exceptions where it is not necessary to obtain consent:
- Images such as x rays, laparoscopic images, ultrasound images, brain scans, pathology slides unless there is a concern about identifying information in which case, authors should ensure that consent is obtained.
- Reuse of images: If images are being reused from prior publications, the Publisher will assume that the prior publication obtained the relevant information regarding consent. Authors should provide the appropriate attribution for republished images.
Consent and already available data and/or biologic material
Regardless of whether material is collected from living or dead patients, they (family or guardian if the deceased has not made a pre-mortem decision) must have given prior written consent. The aspect of confidentiality as well as any wishes from the deceased should be respected.
Data protection, confidentiality and privacy
When biological material is donated for or data is generated as part of a research project authors should ensure, as part of the informed consent procedure, that the participants are made aware what kind of (personal) data will be processed, how it will be used and for what purpose. In case of data acquired via a biobank/biorepository, it is possible they apply a broad consent which allows research participants to consent to a broad range of uses of their data and samples which is regarded by research ethics committees as specific enough to be considered “informed”. However, authors should always check the specific biobank/biorepository policies or any other type of data provider policies (in case of non-bio research) to be sure that this is the case.
Consent to participate
For all research involving human subjects, freely-given, informed consent to participate in the study must be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.
In the case of articles describing human transplantation studies, authors must include a statement declaring that no organs/tissues were obtained from prisoners and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained.
For manuscripts reporting studies involving vulnerable groups where there is the potential for coercion or where consent may not have been fully informed, extra care will be taken by the editor and may be referred to the Springer Nature Research Integrity Group.
Consent to publish
Individuals may consent to participate in a study, but object to having their data published in a journal article. Authors should make sure to also seek consent from individuals to publish their data prior to submitting their paper to a journal. This is in particular applicable to case studies.
Provide “Consent to participate” as a heading (see template)
- Sample statements consent to participate:
- Informed consent was obtained from all individual participants included in the study.
- Informed consent was obtained from legal guardians.
- Written informed consent was obtained from the parents.
- Verbal informed consent was obtained prior to the interview.
- The patient has consented to the submission of the case report for submission to the journal.
Provide “Consent to publish” as a heading (see template)
- The authors affirm that human research participants provided informed consent for publication of the images in Figure(s) 1a, 1b and 1c.
- The participant has consented to the submission of the case report to the journal.
- Patients signed informed consent regarding publishing their data and photographs.
Sample statements if identifying information about participants is available in the article:
- Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
Images will be removed from publication if authors have not obtained informed consent or the paper may be removed and replaced with a notice explaining the reason for removal.
Sex and gender in research (SAGER guidelines)
We encourage our authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ and to include sex and gender considerations where relevant. Authors should use the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) carefully to avoid confusing both terms. Article titles and/or abstracts should indicate clearly what sex(es) the study applies to. Authors should also describe in the background, whether sex and/or gender differences may be expected; report how sex and/or gender were accounted for in the design of the study; provide disaggregated data by sex and/or gender, where appropriate; and discuss respective results. If a sex and/or gender analysis was not conducted, the rationale should be given in the Discussion. We suggest that our authors consult the full guidelines before submission.
**Definition of sex and gender **
Sex - refers to biological differences between females and males, including chromosomes, sex organs, and endogenous hormonal profiles.
Gender - refers to socially constructed and enacted roles and behaviors which occur in a historical and cultural context and vary across societies and over time.
Applications of the guidelines
These guidelines apply to studies involving humans, vertebrate animal and cell lines.
Research involving human participants, their data or biological material
Ethics approval
When reporting a study that involved human participants, their data or biological material, authors should include a statement that confirms that the study was approved (or granted exemption) by the appropriate institutional and/or national research ethics committee (including the name of the ethics committee) and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach and demonstrate that an independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study. If a study was granted exemption from requiring ethics approval, this should also be detailed in the manuscript (including the reasons for the exemption).
Retrospective ethics approval
If a study has not been granted ethics committee approval prior to commencing, retrospective ethics approval usually cannot be obtained, and it may not be possible to consider the manuscript for peer review. The decision on whether to proceed to peer review in such cases is at the Editor's discretion.
Ethics approval for retrospective studies
Although retrospective studies are conducted on already available data or biological material (for which formal consent may not be needed or is difficult to obtain) ethics approval may be required dependent on the law and the national ethical guidelines of a country. Authors should check with their institution to make sure they are complying with the specific requirements of their country.
Ethics approval for case studies
Case reports require ethics approval. Most institutions will have specific policies on this subject. Authors should check with their institution to make sure they are complying with the specific requirements of their institution and seek ethics approval where needed. Authors should be aware to secure informed consent from the individual (or parent or guardian if the participant is a minor or incapable) See also section on Informed Consent.
Cell lines
If human cells are used, authors must declare in the manuscript: what cell lines were used by describing the source of the cell line, including when and from where it was obtained, whether the cell line has recently been authenticated and by what method. If cells were bought from a life science company the following need to be given in the manuscript: name of company (that provided the cells), cell type, number of cell line, and batch of cells.
It is recommended that authors check the NCBI database for misidentification and contamination of human cell lines. This step will alert authors to possible problems with the cell line and may save considerable time and effort.
Further information is available from the International Cell Line Authentication Committee (ICLAC).
Authors should include a statement that confirms that an institutional or independent ethics committee (including the name of the ethics committee) approved the study and that informed consent was obtained from the donor or next of kin.
Research resource identifiers (RRID)
Research Resource Identifiers (RRID) are persistent unique identifiers (effectively similar to a DOI) for research resources. Springer Nature encourages authors to adopt RRIDs when reporting key biological resources (antibodies, cell lines, model organisms and tools) in their manuscripts.
Examples:
- Organism: Filip1tm1a(KOMP)Wtsi- RRID:MMRRC_055641-UCD
- Cell line:RST307 cell line- RRID:CVCL_C321
- Antibody: Luciferase antibody DSHB Cat# LUC-3,- RRID:AB_2722109
- Plasmid: mRuby3 plasmid- RRID:Addgene_104005
- Software: ImageJ Version 1.2.4- RRID:SCR_003070
RRIDs are provided by the Resource Identification Portal. Many commonly used research resources already have designated RRIDs. The portal also provides authors links so that they can quickly register a new resource and obtain an RRID.
Clinical trial registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to assess, improve, maintain, promote or modify health, functioning or health conditions” and a health-related outcome is generally defined as a change in the health of a person or population as a result of an intervention.
To ensure the integrity of the reporting of patient-centered trials, authors must register prospective clinical trials (phase II to IV trials) in suitable publicly available repositories. For example www.clinicaltrials.gov or any of the primary registries that participate in the WHO International Clinical Trials Registry Platform.
The trial registration number (TRN) and date of registration should be included as the last line of the manuscript abstract.
For clinical trials that have not been registered prospectively, authors are encouraged to register retrospectively to ensure the complete publication of all results. The trial registration number (TRN), date of registration and the words 'retrospectively registered’ should be included as the last line of the manuscript abstract.
Purely observational trials will not require registration.
Standards of reporting
Springer Nature advocates complete and transparent reporting of biomedical and biological research and research with biological applications. Authors are recommended to adhere to the minimum reporting guidelines hosted by the EQUATOR Network when preparing their manuscript.
Exact requirements may vary depending on the journal; please refer to the journal’s Instructions for Authors.
Checklists are available for several study designs, including:
- Randomised trials (CONSORT) and Study protocols (SPIRIT)
- Observational studies (STROBE)
- Systematic reviews and meta-analyses (PRISMA) and protocols (PRISMA-P)
- Diagnostic/prognostic studies (STARD) and (TRIPOD)
- Case reports (CARE)
- Clinical practice guidelines (AGREE) and (RIGHT)
- Qualitative research (SRQR) and (COREQ)
- Animal pre-clinical studies (ARRIVE)
- Quality improvement studies (SQUIRE)
- Economic evaluations (CHEERS)
The above should be summarized in a statement and included a section entitled “Declarations” before the reference list. Other declarations include Funding, Conflicts of interest/competing interests, Ethics approval, Consent, Data and/or Code availability and Authors’ contribution statements.
Provide “Ethics approval” as a heading (see template)
Examples of ethics approval obtained:
- All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Medical University of A (No. ...).
- This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University B (Date.../No. ...).
- Approval was obtained from the ethics committee of University C. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
- The questionnaire and methodology for this study was approved by the Human Research Ethics committee of the University of C (Ethics approval number: ...).
Examples of a retrospective study:
- Ethical approval was waived by the local Ethics Committee of University A in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
- This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of XYZ who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of XYZ.
- This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.
Examples no ethical approval required/exemption granted:
- This is an observational study. The XYZ Research Ethics Committee has confirmed that no ethical approval is required.
- The data reproduced from Article X utilized human tissue that was procured via our Biobank AB, which provides de-identified samples. This study was reviewed and deemed exempt by our XYZ Institutional Review Board. The BioBank protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Research involving human embryos, gametes, and stem cells
Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations (See also Research involving human participants and/or animals)
The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent (See also Informed consent) was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.
We encourage authors to follow the principles laid out in the ISSCR Guidelines for Stem Cell Research and Clinical Translation.
In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group.
The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.
Complementary and alternative medicine standards for research
Springer Nature journals are committed to evidence-based research. We believe that Complementary and Alternative Medicine (CAM) research should be held to the same standards and evidence threshold as those of medicine research.
We welcome manuscripts for submission which meet the following clinical research standards:
- Clinical research manuscripts that comply with international and national standards for such work (such as the Declaration of Helsinki or relevant Governmental regulation e.g. the UK’s The Medicines for Human Use (Clinical Trials) Regulations).
- Studies which are adequately controlled (be that compared to a placebo or conventional medicine), blinded (where appropriate), randomised and of sufficient statistical power to confidentially and accurately interpret the effect reported. Studies reporting a CAM treatment/technique compared only to another CAM treatment/technique are not sufficient to test the efficacy of the CAM treatment in question. Studies in which a conventional treatment is supplemented with a CAM technique are only valid if compared to the same conventional treatment supplemented with a placebo.
- CAM treatments/techniques tested on animal models and/or human patients: It is unethical for such work, on humans or animals, to have taken place without adequate prior evidence that the treatment/technique shows some potential of being therapeutic. Manuscripts must include evidence that takes the form of objective, measurable data from previously published peer reviewed literature which adheres to scientific principles (for instance in vitro or cellular work). Other forms of evidence are not valid. Manuscripts describing work lacking this evidence will not be considered on ethical grounds.
Research involving animals and their data or biological material
The welfare of animals (vertebrate and higher invertebrate) used for research, education and testing must be respected. Authors should supply detailed information on the ethical treatment of their animals in their submission. For that purpose they may use the ARRIVE checklist which is designed to be used when submitting manuscripts describing animal research. We recommend that authors consult the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020), as a comprehensive resource for guidance on veterinary best practice for the anesthesia and euthanasia of animals.
For studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.
Authors are recommended to comply with:
- The International Union for Conservation of Nature (IUCN) Policy Statement on Research Involving Species at Risk of Extinctionand consult theIUCN red list index of threatened species,Convention on the Trade in Endangered Species of Wild Fauna and Flora
When reporting results authors should indicate:
- … that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted. Please provide the name of ethics committee and relevant permit number;… whether the legal requirements or guidelines in the country and/or state or province for the care and use of animals have been followed.
Researchers from countries without any legal requirements or guidelines voluntarily should refer to the following sites for guidance:
- The Basel Declarationdescribes fundamental principles of using animals in biomedical research
- The International Council for Laboratory Animal Science(ICLAS) provides ethical guidelines for researchers as well as editors and reviewers
- The Association for the study of Animal Behaviourdescribes ethical guidelines for the treatment of animals in research and teaching
- The International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethicsprovide guidelines for authors on animal ethics and welfare.
Researchers may wish to consult the most recent (ethical) guidelines available from relevant taxon-oriented professional societies.
If a study was granted exemption or did not require ethics approval, this should also be detailed in the manuscript.
The above should be summarized in a statement and included in a section entitled “Declarations” before the reference list. Other declarations include Funding, Conflicts of interest/competing interests, Ethics approval, Consent, Data and/or Code availability and Authors’ contribution statements.
Examples ethics approval obtained:
- All procedures involving animals were in compliance with the European Community Council Directive of 24 November 1986, and ethical approval was granted by the Kocaeli University Ethics Committee (No. 29 12 2014, Kocaeli, Turkey).
- All procedures performed in the study were in accordance with the ARVO Statement for Use of Animals in Ophthalmic Vision and Research. The ethical principles established by the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8523, revised 2011) were followed. The research protocol was approved by the Ethics Committee on Animal Use (Protocol No. 06174/14) of FCAV/Unesp, Jaboticabal.
- This study involved a questionnaire-based survey of farmers as well as blood sampling from their animals. The study protocol was assessed and approved by Haramaya University, research and extension office. Participants provided their verbal informed consent for animal blood sampling as well as for the related survey questions. Collection of blood samples was carried out by veterinarians adhering to the regulations and guidelines on animal husbandry and welfare.
- All brown bear captures and handling were approved by the Ethical Committee on Animal Experiments, Uppsala, Sweden (Application C18/15) and the Swedish Environmental Protection Agency in compliance with Swedish laws and regulations.
- The ethics governing the use and conduct of experiments on animals were strictly observed, and the experimental protocol was approved by the University of Maiduguri Senate committee on Medical Research ethics. Proper permit and consent were obtained from the Maiduguri abattoir management, before the faecal samples of the cattle and camels slaughtered in this abattoir were used for this experiment.
Examples ethics approval not required:
- No approval of research ethics committees was required to accomplish the goals of this study because experimental work was conducted with an unregulated invertebrate species.
- As the trappings of small mammals were conducted as part of regular pest control measures in accordance with the NATO Standardized Agreement 2048 "Deployment Pest and Vector Surveillance and Control ", no approval by an ethics committee was required.
- All experiments have been conducted as per the guidelines of the Institutional Animal Ethics Committee, Department of Zoology, Utkal University, Bhubaneswar, Odisha, India. However, the insect species used in this study is reared for commercial production of raw silk materials, as a part of agro-based industry. Therefore, use of this animal in research does not require ethical clearance. We have obtained permission from the office of Research officer sericulture, Baripada, Orissa, India for the provision of infrastructure and support for rearing of silkworm both in indoor and outdoor conditions related to our study to promote sericulture practices.
Utilization of plants, algae, fungi
Springer value stewardship, transparency, and adhering to governance with regards to collecting and utilizing specimens and conducting experiments and/or field studies. Therefor the journal sets out the following guidelines:
Field studies involving genetically engineered plants must be conducted in accordance with national or local legislation and, if applicable, the manuscript needs to include a statement specifying the appropriate permissions and/or licences.
Authors utilizing genetic plant resources received via local suppliers/collectors, such as species collected from protected areas or endangered species with medical importance, must conduct their experiments following the Nagoya Protocol (as part of the Convention on Biological Diversity).
Authors whose research is focusing on quarantine organisms (i.e. harmful or pest organisms, including plant pathogens) should adhere to national legislation and notify the relevant National Plant Protection Organization of new findings before publication. More information can be found via the International Plant Protection Convention.
In principle, it is recommended that authors comply with:
The International Union for Conservation of Nature (IUCN) Policy Statement on Research Involving Species at Risk of Extinction and consult the IUCN red list index of threatened species, Convention on the Trade in Endangered Species of Wild Fauna and Flora
Voucher specimens ensure that the identity of organisms studied in the field or in laboratory experiments can be verified, and ensure that new species concepts can be applied to past research. Voucher specimens documenting all investigated accessions (for population samples at least one specimen per population) are to be deposited in a public herbarium, for example: Index Herbariorum, or other public collection providing access to deposited material. Information on the voucher specimen and who identified it must be included in the manuscript such as Genus name, species name, author, and year of publication.
*Names of plants, algae and fungi *
Manuscripts containing new taxon names or other nomenclatural acts must follow the guidelines set by the International Code of Nomenclature for algae, fungi, and plants.
Authors describing new fungal taxa should register the names with a recognized repository, such as Mycobank, and request a unique digital identifier which should be included in the published article.
Research involving palaeontological and geological material
Details of palaeontological specimens and geological samples should include clear provenance information to ensure full transparency of the research.
It is recognized that precise provenance information may not be available for older museum collections. In circumstances where providing specific provenance information may compromise the security of palaeontological or geological sites it may be appropriate to exclude detailed locality information.
Samples must always be collected and exported in a responsible manner and in accordance with applicable local and national laws. Any submission detailing new material should include information regarding the requisite permissions obtained and the issuing authority. Authors may be required to provide specific supporting documentation upon request.
Type, figured and cited palaeontological specimens, should be deposited in a recognised museum or collection to permit free access by other researchers in perpetuity. Sufficient information on the repository, including the assigned unique catalogue numbers (where applicable), should be provided to allow the specimens to be traced.
We encourage deposition of 3-D scans of fossil specimens (where appropriate) within a permanent, accessible repository to facilitate study by the scientific community.
Springer Nature requires that submitted content adheres to the United Nations Educational, Scientific and Cultural Organization (UNESCO) normative instruments for the protection of cultural heritage, and Resolutions, Motions, guidance and other statements of the International Union for the Conservation of Nature (IUCN).
Dual use research of concern
Some manuscripts provide information that could be directly misapplied to pose a significant threat to public health, safety or security, agricultural crops and other plants, animals, or the environment. For such information to be published, the benefit to the research community, society, or to public health, must outweigh any risks. We reserve the right to take expert advice in cases where we believe that concerns may arise, and we may require a manuscript to undergo peer review specifically to assess the dual use risk. Where the risk of misuse outweighs any potential benefit, publication is declined; published content may be corrected, retracted or removed.
Researchers are expected to comply with their institutional and funder’s requirements, as well as any national regulations. They should be aware of dual-use concerns related to their work and take steps to minimize misuse of their research. Such concerns include, but are not limited to, biosecurity, nuclear and chemical threats. Where relevant regulations exist, authors should disclose whether their study is subject to consideration as dual use research of concern; if it is, the manuscript should report the authority granting approval and reference number for the regulatory approval. When the study reports material that can be harmful outside the laboratory context, the manuscript should describe appropriate containment (e.g. biosafety) procedures.
We recognize the widespread view that openness in science helps to alert society to potential threats and to defend against them, and we anticipate that only very rarely will the risks be perceived as outweighing the benefits of publishing a paper that has otherwise been deemed appropriate for publication.
Digital image integrity
While a certain degree of image processing is unavoidable for some experiments, fields and techniques, in all instances, the final image presented in the published article must accurately represent the original data and conform to community standards. Authors must take care to exercise caution during data acquisition to avoid misrepresentation of the data collected.
Editors may request the unprocessed data files to help in manuscript evaluation during the peer review process; if these data are unavailable upon request, we may need to halt the peer review process until the issues are satisfactorily resolved.
We may also request unprocessed data when responding to post-publication issues that may arise with published papers. Lack of availability of unprocessed data can make resolution of post-publication issues challenging. We strongly recommend retaining unprocessed data and metadata files after publication, ideally archiving data in perpetuity.
Some journals may require submission of unprocessed original images of gels and blots to be submitted with the final accepted version. These unprocessed images are then published in the Supplementary Information.
-
General image guidelines
-
Do not combine images taken at different times or locations unless clearly indicated as time-averaged or a time-lapse sequence. Clearly separate adjacent images with borders and label and describe each image in the figure legend.
- Avoid using tools that deliberately alter images (e.g., cloning, healing).
- Apply adjustments (brightness, contrast, etc.) uniformly across the entire figure panel , including controls. Do not alter data visibility or selectively emphasize regions.
- Be prepared to provide original, unprocessed or uncropped images upon request. In the event this is not possible, be prepared to present experimental replicates of the images presented.
2. Image processing and acquisition tools
- List all image acquisition tools and software used, including version numbers.
- If custom code is used for processing, provide a full description and make it available in a community repository.
- Fully document all image acquisition settings and processing steps in the Methods section.
3. Electrophoretic gels and blots
- Cropping is acceptable if it improves clarity but mention this in the figure legend. Some journals may require the original, uncropped images in supplementary files.
- Avoid comparing samples across different gels/blots. If necessary, note that the samples are from the same experiment and processed in parallel.
- Use clear separations (e.g., black lines) for cropped together non-adjacent lanes. Include loading controls on the same blot where possible.
- Do not overexpose gels/blots to prevent loss of faint bands. If high contrast is needed, provide multiple exposures in the Supplementary Information.
- All papers containing blots should provide uncropped images with the membrane edges clearly visible as a supplementary information file ready for peer-review.
4. Microscopy
- Do not group cells from different fields in one image; use Supplementary Information to show additional fields.
- Apply image adjustments uniformly. Any use of pseudo-colouring, threshold adjustments, or gamma changes must be disclosed in the figure legend.
- Ensure all microscopy images are presented with scale bars and/or indicated magnification. Images from different groups shown side-by-side should be presented at the same magnification to allow accurate visual comparison.
- Specify equipment details (e.g., microscopes, cameras, lenses) and list key acquisition settings in the Methods section. Mention any processing software used and describe manipulations such as deconvolution, 3D reconstructions, or thresholding.
- State the image resolution and any processing done to enhance it.
- All colour scales must be defined and intensity levels must be provided in either the figure or its associated legend.
These guidelines help ensure that images accurately represent your data, maintaining transparency and trust in your published research.
Data availability and standards of reporting
Data availability statement
Reproducibility of scientific claims is integral to the integrity of published research. At the heart of research claims is the data from which results are obtained and conclusions are drawn. Without access to the original data, scientific claims can be difficult (if not impossible) to replicate. Mandatory data availability statements consolidate information on availability of data associated with the manuscript, whether data are in repositories, available on request, included with supplementary information or figure source data files.
This policy requires all Springer, Discover and Palgrave Macmillan journals to implement a research data policy which requires data availability statements. This policy does not introduce any data sharing mandates, but aims to make the availability of the data transparent. For information whether or not this policy has yet been fully implemented by a journal, please check the journal's submission information. Please note that full implementation in all journal make take some time to achieve.
Upon implementation of this policy, all Springer, Discover and Palgrave Macmillan journals will satisfy the requirements of Level 1 ToP (Transparency and Openness Promotion) Guidelines. Springer Nature was an early signatory in this initiative that aims to promote transparency and reproducibility in research.
Note: We strongly recommend that authorship is anonymized in data when a journal operates double-blind peer review. A number of repositories have features to support this, providing peer review access via links that don’t include author information. These links provide private access before the data is publicly available. You can find more details on this in our repositories FAQs.
Standards of reporting
Springer Nature advocates complete and transparent reporting of research. For biomedical and biological research, the checklists below must be completed before peer review, and made available to the Editors and reviewers.
- Randomized controlled trials: CONSORT
- Randomized controlled trial protocols: SPIRIT
- Systematic reviews and meta-analyses: PRISMA
- Case reports: CARE
- Preclinical animal studies: ARRIVE
In addition, Springer Nature strongly encourages the use of the following checklists and reporting guidelines:
Peer review
Introduction
All research articles, and most other article types, published in Springer journals undergo peer review. This usually involves review by at least two independent, expert peer reviewers. Individual journals may differ in their peer review processes (e.g. open or anonymized), please refer to the specific journal for details.
Peer review policy
All submissions to Springer journals are first reviewed for completeness and only then sent to be assessed by an Editor who will decide whether they are suitable for peer review. Where an Editor is on the author list or has any other competing interest regarding a specific manuscript, another member of the Editorial Board will be assigned to oversee peer review. Editors will consider the peer-reviewed reports when making a decision, but are not bound by the opinions or recommendations therein. A concern raised by a single peer reviewer or the Editor themself may result in the manuscript being rejected. Authors receive peer review reports with the editorial decision on their manuscript.
Proceedings papers are reviewed by the Programme Chairs and Programme Committee members of the respective conference, with help from external reviewers selected by them.
Peer reviewer selection
Peer reviewer selection is critical to the publication process. It is based on many factors, including expertise, reputation, specific recommendations, conflict of interest and previous performance. Speed, thoroughness, sound reasoning and collegiality are highly desirable.
Editor responsibilities (from the Springer Nature Code of Conduct for Editors):
- Editor(s) are expected to obtain a minimum of two peer reviewers for manuscripts reporting primary research or secondary analysis of primary research. It is recognized that in some exceptional circumstances, particularly in niche and emerging fields, it may not be possible to obtain two independent peer reviewers. In such cases, Editor(s) may wish to make a decision to publish based on one peer review report. When making a decision based on one report, Editor(s) are expected to only do so if the peer review report meets the standards set out below.
- Peer review reports should be in English and provide constructive critical evaluations of the authors’ work, particularly in relation to the appropriateness of methods used, whether the results are accurate, and whether the conclusions are supported by the results. Editorial decisions should be based on peer reviewer comments that meet these criteria rather than on recommendations made by short, superficial peer reviewer reports which do not provide a rationale for the recommendations.
- Editor(s) are expected to independently verify the contact details of reviewers suggested by authors or other third parties. Institutional email addresses should be used to invite peer reviewers wherever possible. Each manuscript should be reviewed by at least one reviewer who was not suggested by the author.
- Manuscripts that do not report primary research or secondary analysis of primary research, such as Editorials, Book Reviews, Commentaries or Opinion articles, may be accepted without peer review. Such manuscripts should be assessed by the Editor(s) if the topic is in the area of expertise of the Editor(s); if the topic is not in area of expertise of the Editor(s), such manuscripts should be assessed by at least one independent expert reviewer or Editorial Board Member.
In the rare, exceptional, occasions when two independent peer reviewers cannot be secured, the Editor may act as a second reviewer or make a decision using only one report.
- Editor must have a sufficient amount of knowledge in the area if acting as a second reviewer
- Editor should sign the review to ensure transparency in the peer review process
- Any single reports should be detailed and thorough
- The first reviewer should be senior, on topic and have published recently on the subject
Potential peer reviewers should inform the Editor of any possible conflicts of interest before accepting an invitation to review a manuscript. Communications between Editors and peer reviewers contain confidential information that should not be shared with third parties.
Some journals allow authors to suggest potential reviewers, and to request that some be excluded from consideration (usually a maximum of two people/research groups). Editors will consider these requests, but are not obliged to fulfill them. The Editor's decision on the choice of peer reviewers is final.
Authors should not recommend recent collaborators or colleagues who work in the same institution as themselves. Authors can suggest peer reviewers in the cover letter. Information which will help the Editor verify the identity and expertise of the reviewer will be required. This includes the suggested reviewer’s institutional email address and ORCID or Scopus ID.
Peer reviewer diversity
Springer Nature is committed to diversity, equity and inclusion and we strive for diverse demographic representation of peer reviewers. Editors are strongly encouraged to consider geographical regions, gender identities, racial/ethnic groups, and other groups when inviting peer reviewers.
Peer reviewer misconduct
Providing false or misleading information—for example, identity theft and suggesting fake peer-reviewers—will result in rejection of the manuscript, further investigation in line with Springer Nature’s misconduct policy, and notification to the authors’ institutions/employers. Springer journals are members of the Committee on Publication Ethics (COPE). More information about peer reviewer fraud/falsification can be found here.
Peer review models
- Open peer review: Peer reviewers' names are included on the peer review reports. If the manuscript is published, reports with peer reviewer names are published online alongside the article(on rare occasions, information from the pre-publication history may not be available for a specific article). Authors are aware of the peer reviewers’ names during the peer-review process and vice versa. There should not be direct correspondence between authors and peer reviewers; communication is mediated by the Editor.
- Transparent peer review: If the manuscript is published, the peer review reports appear online alongside the article. Names of peer reviewers are not published. On rare occasions, information from the pre-publication history may not be available for a specific article.
- Anonymized peer review: Most journals use a single-anonymized peer review process; that is, author identities are known to peer reviewers, but peer reviewers identities are not revealed to the authors. In double-anonymized peer review, identities of neither authors nor peer reviewers are disclosed; peer review mediated by Research Square is double-anonymized. The pre-publication history of articles is not made available online.
Peer reviewer guidance
The primary purpose of peer review is providing the Editor with the information needed to reach a fair, evidence-based decision that adheres to the journal’s editorial criteria. Review reports should also help authors revise their paper such that it may be accepted for publication. Reports accompanied by a recommendation to reject the paper should explain the major weaknesses of the research; this will help the authors prepare their manuscript for submission to a different journal.
Peer reviewers should adhere to the principles of COPE's Ethical Guidelines for Peer-reviewers.
Confidential comments to the Editor are welcome, but they must not contradict the main points in the report for the authors.
Peer reviewers should assess papers exclusively against the journal’s criteria for publication.
The following conventions should be respected:
- Reviewers should review the peer review policy of the Journal before revealing their reviewer role.
- Reviews should be conducted objectively.
- Personal criticism of the author is inappropriate, as are defamatory/libelous remarks.
- Reviewers should express their views clearly with supporting arguments and references.
- Reviewers should declare any potential competing interests.
- Reviewers should decline to review manuscripts with which they believe they have a competing interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
- Reviewers should respect the confidentiality of material supplied to them and not discuss unpublished manuscripts with colleagues or use the information in their own work.
- Any reviewer who wants to pass a peer review invitation onto a colleague must contact the journal in the first instance.
Concerns relating to these points, or any aspect of the review process, should be raised with the editorial team.
We ask reviewers the following types of questions, to provide an assessment of the various aspects of a manuscript:
- Key results: Please summarize what you consider to be the outstanding features of the work.
- Validity: Does the manuscript have flaws which should prohibit its publication? If so, please provide details.
- Originality and significance: If the conclusions are not original, please provide relevant references.
- Data & methodology: Please comment on the validity of the approach, quality of the data and quality of presentation. Please note that we expect our reviewers to review all data, including any extended data and supplementary information. Is the reporting of data and methodology sufficiently detailed and transparent to enable reproducing the results?
- Appropriate use of statistics and treatment of uncertainties: All error bars should be defined in the corresponding figure legends; please comment if that’s not the case. Please include in your report a specific comment on the appropriateness of any statistical tests, and the accuracy of the description of any error bars and probability values. Evaluation checklists can be found here.
- Conclusions: Do you find that the conclusions and data interpretation are robust, valid and reliable?
- Inflammatory material: Does the manuscript contain any language that is inappropriate or potentially libelous?
- Suggested improvements: Please list suggestions that could help strengthen the work in a revision.
- References: Does this manuscript reference previous literature appropriately? If not, what references should be included or excluded? Attempts at reviewer-coerced citation will be noted against your record in our database.
- Clarity and context: Is the abstract clear, accessible? Are abstract, introduction and conclusions appropriate?
- Please indicate any particular part of the manuscript, data, or analyses that you feel is outside the scope of your expertise, or that you were unable to assess fully.
- Please address any other specific questions asked by the editor.
- Please make sure to check if author(s) have followed our Sex and Gender in Research (SAGER Guidelines).
- Reviewers should alert the Editor-in-Chief/Springer Nature (contact person from respective journal) if they wish to make an allegation of publication or research misconduct, e.g. plagiarism or image manipulation, about an article they are reviewing.
Before you submit your report, please take a moment to read it through and put yourself in the place of the authors. How would you feel if you received this report? Would the tone offend you? Is it courteous and professional? Are there unnecessary personal remarks or antagonistic comments about the authors or their competitors? Please note that the Editor reserves the right to remove any inappropriate language from your report.
Reports do not necessarily need to follow this specific order but should document the peer reviewer’s thought process. Some journals have a set of questions that reviewers will need to specifically address. All statements should be justified and argued in detail, naming facts and citing supporting references, commenting on all aspects that are relevant to the manuscript and that the reviewers feel qualified commenting on. Not all of the above aspects will necessarily apply to every paper, due to discipline-specific standards. When in doubt about discipline-specific peer-reviewing standards, reviewers can contact the Editor for guidance.
Springer Nature is committed to diversity, equity and inclusion. The peer reviewer should flag any concerns that may affect this commitment.
It is our policy to remain neutral with respect to jurisdictional claims in published maps and institutional affiliations, and the naming conventions used in maps and affiliation are left to the discretion of authors. Peer reviewers should not, therefore, request authors to make any changes to such unless it is critical to the clarity of the academic content of a manuscript.
Springer journals are committed to rapid editorial decisions and publication, and we believe that an efficient editorial process is a valuable service both to our authors and to the research community as a whole. We therefore ask reviewers to respond promptly within the number of days agreed. If reviewers anticipate a delay, we ask them to let us know so that we can keep the authors informed and, where necessary, find alternatives.
Peer reviewer recognition
Springer Nature is committed to recognizing the invaluable service performed by our dedicated peer reviewers. As part of our appreciation program, we offer our peer reviewers the opportunity to credit their ORCID profile (where available) with verified peer review data transmitted directly from the submission system at the time of report submission.
Collections and special issues
Collections and special issues may include original primary research articles, reviews, and other content types published by the journal.
All manuscripts submitted to Springer journal collections or special issues are assessed according to the journal’s standard editorial criteria and are subject to all of the standard editorial policies, including the competing interests policy. The content of the submission will also be assessed to ensure it lies within the scope of the collection or special issue.
All submissions that meet the journal’s criteria for peer review will undergo the journal’s standard peer review process. Please visit the journal’s website for information on the review process used. The peer review of any submissions for which the editors of the collection or special issue, have competing interests is handled by another editor, who has no competing interests, to ensure the evaluation of these submissions is objective.
Act with integrity
We expect our staff and all researchers engaging with Springer Nature to act with integrity. This means we uphold the principles of honesty, accountability, fairness, and compliance with legal and ethical standards and rule: honesty about who we are and what we are doing, accountability for our actions, fairness in our dealings with others and a demonstration of compliance with all applicable rules and regulations. We expect these same standards from staff and stakeholders. If we have reason to believe that these principles are not being honoured, we reserve the right to bring serious cases to the attention of employers or local authorities, if needed, and may refuse to interact, or do business, with individuals who repeatedly or seriously violate this policy.
Manuscripts submitted by authors we find to be in breach of this policy will immediately be withdrawn. If we become aware of a breach of policy post publication we will investigate, and this may lead to post-publication action.
Ethics & disclosures
The journal is committed to maintaining the highest level of integrity in the content published.
This journal has a competing interest policy in place.
All Springer Nature journals require authors to comply with international, national and/or institutional standards of research reporting. This is particularly important for studies involving human and/or animal participants, their data and biological material, and Informed Consent.
The journal is a member of the Committee on Publication Ethics (COPE). It subscribes to COPE's principles for addressing misconduct. This means the journal is committed to investigating any allegations of misconduct, to maintain the integrity of research.
The journal may use plagiarism detection software to screen submissions. If plagiarism is identified, the (COPE) guidelines on plagiarism will be followed.
Research content published in this journal is peer reviewed (single-anonymous).
Privacy policy
This policy was last updated on 16th June 2026.
This is the privacy policy ("policy") for SpringerNatureLink which is run and provided by Springer Nature Limited (we, us and our). Springer Nature Limited is located at The Campus, 4 Crinan Street, London N1 9XW. We can also be contacted at https://support.nature.com/en/support/home
We will only use the personal data gathered over this website as set out in this policy. Below you will find information on how we use your personal data, for which purposes your personal data is used, with whom it is shared and what control and information rights you may have.
I. Summary of our processing activities
We publish scholarly journals, books, news and data. Some of this material is freely available; some of it is only available to subscribers. The following summary offers a quick overview of the data processing activities that are undertaken on our website. You will find more detailed information under the indicated sections below.
- When you visit our website for informational reasons without setting up an account, only limited personal data will be processed to provide you with the website itself (see III).
- If you are identified as belonging to a customer organisation then we collect information in order to be able to provide usage reporting to that customer.
- In case you register for one of our services, use the submission and peer review systems or subscribe to our newsletters, further personal data will be processed in the scope of such services (see IV and V).
- Furthermore, your personal data will be used to provide you with relevant advertising for our services and products (see VII) and for statistical analysis that helps us to improve our website (see VIII). Additionally, we improve your website experience with third party content (see IX).
- Your personal data may be disclosed to third parties (see X) that might be located outside your country of residence; potentially, different data protection standards may apply (see XII).
- We have implemented appropriate safeguards to secure your personal data (see XIII) and retain your personal data only as long as necessary (see XIII).
- Under the legislation applicable to you, you may be entitled to exercise certain rights with regard to the processing of your personal data (see XIV).
- When you view on-demand video on our websites, we may collect your viewing and usage information, and we may share information that identifies you as having viewed particular video content with service providers that enable video functionality, personalization, and usage analysis and third parties for advertising and marketing, as well as editorial purposes.
II. Definitions
- Personal data: means any information relating to a natural person who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, or an online identifier.
- Processing: means any operation which is performed on personal data, such as collection, recording, organisation, structuring, storage, adaptation or any kind of disclosure or other use.
III. Informational use of the website
When you visit our website for informational reasons, i.e. without registering for any of our provided services listed under IV and without providing us with personal data in any other form, we may automatically collect additional information about you which will contain personal data only in limited cases and which is automatically recognised by our server.
Examples might include:
- your IP address;
- your device type, name and IDs;
- the date and time of your requests;
- the content of your requests;
- information on your browser version;
- your screen resolution;
- information on your operating system, including language settings.
- information about video content that you viewed.
We use such information only to assist us in providing an effective service (e.g. to adapt our website to the needs of your device or to allow you to log in to our website), and to collect broad demographic information for anonymised, aggregated use.
If you are identified by IP or equivalent method as belonging to a customer organisation such as university or a company then we will also collect the identity of that organisation and use it to create usage reports which show the organisation how much of the content we publish is being read by their students, members or employees. This information does not contain anything related to a personal login unless (a) you are a nominated administrator for that organisation or (b) your organisation specifically requires it as a part of a usage-based access contract.
The personal data automatically collected is necessary for us to provide the website, Article 6 sec. 1 sent. 1 lit. b GDPR, and for our legitimate interest to guarantee the website's stability and security, Article 6 sec. 1 sent. 1 lit. f GDPR.
IV. Registration for our services
Access to subscription content is provided via a variety of mechanisms such as IP site licenses, login via third party federated identity providers or by a personal account with us. Using the federated authentication method institutional selection data may be stored locally in your browser and shared with third party websites that you visit to ease the process of institutional authentication. If your access to our content is provided by an organisation or an institution like a university or a company then they choose the access method on your behalf. A personal account is required to purchase content directly from us, or to receive personal services like newsletters and alerts.
If you need to create a personal login with us then we will store and process the following:
- Information (such as your name, telephone number, user name and email address) that is provided by registration;
- Information in connection with an account sign-in facility (e.g. log-in and password details);
- Communications sent by you (e.g. via e-mail or website communication forms).
The information that is necessary for the performance of the service is labelled accordingly. All further information is provided voluntarily.
We will process the personal data you provide to:
- Identify you at sign-in;
- Provide you with the services and information offered through the website or which you request;
- Administer your account;
- Communicate with you;
- (behavioural) Advertising and profiling;
- Facilitate attendance of a conference;
- Manage manuscript submissions;
- Provide access (where appropriate) to other Springer Nature group content if you so request
For this, the legal basis is Article 6 sec. 1 sent. 1 lit. b GDPR. The use of your personal data for behavioural advertising and profiling is done with consent, Article 6 sec. 1 sent. 1 lit. a GDPR.
We use the personal data and contact data you provide by registration to inform you directly about our additional products and services. The use of your personal data for directly advertising related products and services is with consent, Article 6 sec. 1 sent. 1 lit. a GDPR.
You can object to the use of your personal data for direct marketing at any time. We will then refrain from any processing to the extent it is related to such purposes. You may opt-out of direct marketing via opt-out links in any marketing communication or via user profile pages on the website (where available). You can also inform us about your objection by contacting our Data Protection Office at [email protected].
We offer notification services such as table-of-contents or new book alerts. This service is provided by means of a double-opt-in. Thus, you will receive an email containing a link by which you can confirm that you are the owner of the email address and wish to be notified via our email service. You can end this service by opting out via the link provided in each notification email. This notification service is based on your consent, Article 6 sec. 1 sent. 1 lit. a GDPR.
Registration data is kept until such time as an account deletion request is made. If such a request is received we will erase your data within 30 days. Statutory storage obligations or the need for legal actions that may arise from misconduct within the services or payment problems can lead to a longer retention of your personal data. In this case, we will inform you accordingly.
V. Information about the specific uses that require registration/identification
1. Blogs
You can publicly comment on our blog where we post a variety of articles to inform you about our activities. When posting a comment your name or user name will be made public. To be able to comment on our blog you will have to register as described in IV.
In addition to the extent of processing described under IV, when you post a comment we will retain some of your personal data such as your IP address and name and other metadata such as time of posting. This is necessary to defend ourselves from possible liability claims that may arise from unlawful comments posted by you and reflects our legitimate interest with regard to the legal justification of this processing activity in Article 6 sec. 1 sent. 1 lit. f GDPR.
We reserve the right to delete comments that are off-topic, spam, abusive, use excessive foul language, include ad hominem attacks or offend against legal regulations.
2. Web shop
For the use of our web shop you have to set up an account as described under IV. Your customer account retains your personal data for future purchases. You can delete the personal data as well as the account in your account's settings. This processing is based on Article 6 sec. 1 sent. 1 lit. b.
By statutory law we are required to retain the provided financial data in relation to transactions (including address, payment and order information) for ten years. However, after 2 years we will restrict the processing of your personal data to comply with the statutory requirements and will not process the personal data any further. Regarding this, the retention of your personal data is based on Article 6 sec. 1 sent. 1 lit. c GDPR.
When purchasing a product that requires shipping we may share the delivery data with a Contractor to provide shipment tracking to you. Such a transfer will be based on data processing agreements in accordance with Article 28 of the GDPR. Therefore, our Contractors will only use your personal data to the extent necessary to perform their functions and will be contractually bound to process your personal data only on our behalf and in compliance with our requests.
3. Article alerts and newsletters
With your email address you can subscribe to our newsletters that provide you with the latest news about our products and services if you consent to receiving such newsletters. The legal basis for this processing is Article 6 sec. 1 sent. 1 lit. a GDPR. Your email address will be retained as long as you subscribe to our newsletters.
You can unsubscribe from this service by opting out via the link provided in each newsletter.
You can sign up for newsletters and request to be contacted about our products and services via Facebook. For this purpose, we are using Facebook Lead Ads, a service of Meta Platforms Inc, 1 Hacker Way Menlo Park, California 94025, USA ("Meta"). Lead Ads makes it even easier for you to sign up to newsletters and request to be contacted as the form will already be pre-populated via Facebook with your data and you only need to submit the form. Of course, you have the opportunity to amend and review the data before submission. For more information on how lead ads works see here - https://www.facebook.com/business/ads/lead-ads.
The legal basis for this processing is Article 6 sec. 1 sent. 1 lit. a GDPR. Your email address will be retained as long as you subscribe to our newsletters or until you request the removal of your email address.
You can unsubscribe from newsletters by opting out via the link provided in each newsletter. If you inquired about a product or service and no longer wish to be contacted, you can email [email protected], citing the name of the product or service, and request that your email address be removed.
4. Manuscript submission and Peer Review
Our Submission and Peer Review System offers the services of peer review, content preparation and proofing, publication and dissemination of research. In order to use the aforementioned services you have to set up an initial account. Where optional paid services may be engaged, you will be prompted to set up an additional, or enhance an existing account.
With regard to the registration of an account and its subsequent use, we process the following information.
- Information that is provided by registration such as your name, user name and email address.
- Information in connection with an account sign-in facility, e.g. log-in and password details;
- Communications sent by you, e.g. via e-mail or website communication forms.
- Content files and covering letters provided by you
- Grants, funding, membership, institution, society, committee registration
- Billing or invoicing information
- Information received from societies we work with, e.g. address, name, email address
The information that is necessary for the performance of the service is labelled accordingly.
We will process the personal data you provide in order to:
- Identify you at sign-in;
- Administer your account;
- Provide you with the services and information offered through the Submission and Peer Review System or which you additionally request;
- Communicate with you;
- Process payments
- Provide information to you as an Author about other publishing opportunities, with the Springer Nature group, you can stop these communications at any time by clicking the link in each email or contacting customer services;
- Communicate with you in your capacity as a current or potential Peer Reviewer, Editorial Board Member, or external Editor to provide information about the journal (s) and content you have worked on; you can stop these communications to you as a Peer Reviewer, Editorial Board Member, or external Editor at any time by clicking the link in each email or contacting Customer Service at https://support.nature.com/en/support/home. Stopping these communications will not affect your status as Peer Reviewer, Editorial Board Member or external Editor with respect to the journal.
- Create a profile of your publication record based on publicly available data, such as published books and articles, citations and grants awarded. This information will not be used to determine article acceptance, nor will it be used for automated decision making (see section VI for more information on automated decision making). This information will be used to personalise communications and provide you with the latest news about our products and services;
- To ensure the accuracy of content attribution and the quality and integrity of the peer review process
- Provide you with e-alerts
- Offer to transfer your submission to an alternative Springer Nature title if applicable
- Authorise and process Article Publication Charges (APCs)
As an author, we’ll highlight publishing opportunities in the form of recommendations via our Researcher Home website. We’ll use your publishing history to do this. You can opt out of these recommendations at any time by emailing https://support.nature.com/en/support/home.
For this, the legal basis is Article 6 sec. 1 sent. 1 lit. b GDPR, and for our legitimate interest in optimizing our services and preventing fraud, Article 6 sec. 1 sent. 1 lit. f GDPR.
We use Permutive cookie data to recommend relevant content to you based on your reading history. For this activity, the legal basis to process your data is Article 6 sec. 1 sent. 1 lit. a GDPR. This reflects your consent to non-essential cookies that help with communications and marketing. You can update or withdraw your consent by clicking Your Privacy Choices/Manage cookies in the page footer. You can also opt out of these recommendations at any time by selecting "Opt out of personalised recommendations."
Your personal account registration data is, in the absence of exceptions within the specific services mentioned, retained for as long as your account is used. Non-activity is defined at a minimum of three years, to facilitate ease-of-return for account holders. Content and communications, associated with submissions, reviews or decisions made by an account holder is held for a period of 12 months following final decision before being stored within long term limited-access archiving. Content may be engaged in relation to the services provided and in the interests of the integrity of published material. Such a decision will be made under the oversight of the Springer Nature Research Integrity Group. The need for legal actions within the services or payment problems can lead to a longer retention of your personal data.
In order to ensure the high quality of our journals and publications as well as the significance of the scientific research published, we have implemented a peer review procedure.
In order to find and contact suitable and qualified peer reviewers within the relevant research community, editorial team members may process some of your basic personal data (i.e. Email address, name and research interest) to register you for our Peer Review System. The legal basis for processing your personal data is our and the Publisher's or the respective editor's legitimate interest in finding and contacting suitable and qualified peer reviewers to ensure the high level of papers and articles published in our journals, Art. 6 (1) sent. 1 lit. f GDPR.
As a Peer Reviewer or external Editorial Board Member we will contact you from time to time about the journal(s) and content that you have worked on, Art. 6 (1) sent. 1 lit. f.
If you do not wish to be contacted any longer, you can contact us via our support portal. Please note that we may keep some of your personal data to recall your explicit wish to not be contacted for any peer review procedure in the future and thus, to prevent any future processing of your data in this regard. The legal basis for this is our and your legitimate interest in recalling your wish and preventing any future contacting, Article 6 (1) sent. 1 lit. f GDPR.
5. Author and instructor services
If you use the author and instructor services the required data are retained for the duration of the process plus a security period. Regarding this, the retention of your personal data is based on Article 6 sec. 1 sent. 1 lit. b GDPR.
If you have qualified for an author discount for purchasing books, the retention periods of the web shop are applicable (see above).
To request a free online review copy of a book we use the contact data in your account to process the request.
6. Customer service
If you contact us by either
- e-mail or physical mail
- telephone or fax
- Chat/messaging support
- through a website communication or submission form
we will process the personal data you provide to process and fulfil your request. For this, the legal basis is Article 6 sec. 1 sent. 1 lit. a and b GDPR.
To provide the requested service your data may be stored in a ticketing system and/or on a support platform to enable data access by the relevant customer support team member. Where appropriate the data will also be forwarded to a different team to fulfil the request (e.g. to update your data) or be used on physical data records, e.g. invoices.
We use Freshdesk (provided by Freshworks GmbH, Neue Grünstraße 17, 10179 Berlin, Germany) as a ticketing system to store and process your requests. Depending on the region you call from and team providing support we use different telephony solutions. For the most part, customers contacting customer service are directed to our level 1 teams at our Philippines-based data processor Straive (77 Robinson Road, # 13-00 Singapore 068896), if necessary, the service ticket is forwarded to a local level 2 Springer Nature Customer Service team or another relevant team at Springer Nature.
We do not process any sensitive data unless provided by you because you e.g. need support in coping with access issues due to a disability or reveal any protected characteristics during communication. For this, the legal basis is Article 6 sec. 1 sent. 1 lit. a GDPR.
We share anonymous, aggregated data within the business. We forward emails internally, or provide access to tickets for other teams to e.g. share positive feedback with a stakeholder, or for review by internal teams seeking to improve the products and services. For this the legal basis is Article 6 sec. 1 sent. 1 lit. f GDPR and represents our legitimate interest to improve our service quality and provide tailored solutions to the customers.
We store your data until completion of the request and, if applicable, as long as required by statutory retention requirements (e.g. for 3 years after completion to prove adequate handling of service requests or subject access requests made under the GDPR).
7. Ask about this article
This service uses third-party AI functionality. If you use this service, any data you input will be processed by our partners Langfuse and OpenAI, who act as Data Processors on our behalf. This use of the data you input is done with your consent, Article 6 sec. 1 sein nt. 1 lit. a GDPR.
VI. Automated decision making
We do not use your personal data for automated decision making which produces legal effects concerning you or similarly significantly affects you; however we do use your personal data to offer you content and services which we believe may be of interest.
VII. Online advertising, e-commerce and related tools
We use marketing services to provide you with interesting offers. For this purpose, we place advertisements via advertising service providers that use cookies and/or web beacons that are activated when you visit our website. Cookies are small text files that are stored locally in the internet browser and allow recognition of a user. Web beacons are small image files, which allow log file recording and log file analysis. To present online advertising we use the services of, inter alia, Google AdExchange, Google AdSens. Respective advertisement is labelled as "ADVERTISEMENT" or "AdChoices".
The cookies and web beacons enable our service providers to collect information about you and your surfing behaviour, e.g. IP address, browser information, information on user activities, including video content that you viewed, and click data, and to recognize visitors to our website under a pseudonym and only display products that are likely to be of interest to our visitors. Most of the tools use pseudonymised or aggregated data, e.g. shortened IP addresses. The data is used to analyse the use of our website and, thereby, improve and optimize the website and to display advertising tailored to your needs. We collect this data (to improve your website experience and to promote our products and services). You can update your preferences via the "Your privacy choices/Manage cookies" link in the page footer.
Personal data collected via first party cookies is based on consent, Article 6 sec. 1 sent. 1 lit. a GDPR, to improve your website experience and promote our products and services. We collect this data via a cookie management tool; you can update your preferences via the "Your privacy choices/Manage cookies" link in the page footer.
Personal data collected via third party targeting cookies is based on your consent, Article 6 sec. 1 sent. 1 lit GDPR. You can update your preferences via the "Your Privacy Choices/Manage Cookies" link in the page footer.
Please note that we neither have the control of the extent of personal data that is collected by the respective plug-in provider nor do we know the processing's purpose or the period your personal data will be retained. Your personal data will be transferred to and processed inside and outside of the EEA. For further information about the potential risks of a cross border data transfer refer to XI.
It is possible that the above providers may disclose your personal data to its business partners, third parties or authorities.
You can prevent the installation of such a cookie (i) by a respective setting of your browser that blocks the installation of third party cookies, (ii) by deactivating the interest-related advertising under https://www.google.co.uk/ads/preferences, (iii) generally blocking cookies under https://www.google.co.uk/settings/ads/plugin or (iv) by deselecting the option for tracking cookies via the Springer Nature cookie preference centre.
Google AdWords Remarketing and Facebook Custom Audience
In this Website, we use the remarketing or "Similar audiences" feature of AdWords offered by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043 USA, hereinafter referred to as "Google"
Google uses Cookies/tracking technologies, i.e., text files that are stored on your computer and that allow us to analyze your use of our Website. Information generated by Cookies/tracking technology on your use of this Website (including your IP address) will be transferred to a Google server in the U.S. and stored on that server. After that, the last three digits of the IP address will be deleted by Google so that it is no longer possible to clearly match this IP address with personal data. Google will use this information to analyze your use of the Website, to create website activity reports for the website operators and to provide additional services in connection with the use of the Website and the Internet. Furthermore, Google may transfer this information to third parties, if it is required to do so in accordance with statutory provisions or if third parties process data on behalf of Google.
Third party providers, including Google, place advertisements on websites on the Internet. Third party providers, including Google, use stored Cookies/tracking information to place advertisements based on previous visits of a user on this Website.
For additional information on the anonymous analysis of your search behaviour please refer to:
- https://support.google.com/analytics/answer/6004245?hl=de
- http://www.google.com/policies/technologies/ads/
You may object to data collection and storage for the purpose of remarketing at any time - this objection will be effective for the future, but not retroactively - by deactivating interest-based advertising in Google or by deactivating the services on the website of the Network Advertising Initiative. Note: in that case, you may not be able to use all features of this Website anymore. By using this Website, you grant your consent to the processing of data collected about you by Google in the manner and for the purpose described above.
Furthermore, this Website uses retargeting tags and Custom Audience, a service of Meta Platforms Inc, 1 Hacker Way Menlo Park, California 94025, USA ("Meta").
When you visit our web pages, remarketing tags will build a direct connection between your browser and the Facebook server. This way, Facebook learns that you have visited our web page with your IP address. This will enable Facebook to match your visit of our pages with your user account. The information obtained this way can be used to display Facebook ads. Please note that we as the provider of the webpages do not receive any information on the contents of data transferred and their use by Facebook.
With regard to the use of Custom Audience we would like to point out that Facebook and third parties use cookies, web beacons or similar technologies to collect or gather information on this Website. Based on the data gained we can make our Facebook activities more efficient and, e.g., arrange for contents or ads to be shown only to visitors of our Website. The data collected this way will be encrypted and transferred to Facebook and is anonymous for us, e.g., we cannot see personal data of individual users.
For further information on the privacy policy of Facebook and Custom Audience please refer to https://www.facebook.com/about/privacy/ or https://www.facebook.com/business/a/online-sales/custom-audiences-website.
If you do not wish your data to be collected via Custom Audience, you can deactivate Custom Audience using this link.
HubSpot and SAP Marketing Cloud (SMC)
HubSpot and SMC use cookies, Google Analytics, and a pseudonymized user ID to aggregate user behaviour on the website and in emails in order to personalize the content that is provided to newsletter subscribers. Google Analytics does not receive individual email addresses or other personal data, only a number. That number can only be connected to a specific user on Springer Nature's systems. The legal basis for this process is your consent to the use of cookies on our website (Article 6 sec. 1 sent. 1 lit. a GDPR.). You can always unsubscribe from this process by rejecting the cookies that measure website use.
Hotjar
Hotjar is a behaviour and analytics software provided by Hotjar LTD, Dragonara Business Centre, 5th Floor, Dragonara Road, Paceville St Julian's STJ 3141 Malta. We use Hotjar in order to better understand our users' needs and to optimize our service and experience. Hotjar is a technology service that helps us better understand our users' experience (e.g. how much time they spend on which pages, which links they choose to click, what users do and don't like, etc.) and this enables us to build and maintain our service with user feedback. Hotjar uses cookies and other technologies to collect data on our users' behaviour and their devices and may include recording of sample behaviours. This includes a device's IP address (processed during your session and stored in a de-identified form), device screen size, device type (unique device identifiers), browser information, geographic location (country only), and the preferred language used to display our website. Hotjar stores this information on our behalf in a pseudonymized user profile. Hotjar is contractually forbidden to sell any of the data collected on our behalf. The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. a GDPR and reflects your consent to non-essential cookies.
Amplitude
Amplitude provides analytics and event-tracking software. We use Amplitude to better understand user behaviour (e.g. which pages they visit, and which links they click). This helps us to optimise online service and user experience. Amplitude uses cookies to collect data on user behaviour. This includes browsing activity, history, location, operating system, language, device information, and IP addresses amongst others. Amplitude acts as a data processor on our behalf and we have a data processing agreement in place to support this. The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. a GDPR and reflects user consent to non-essential cookies. User consent can be removed by rejecting non-essential cookies in the privacy preference centre.
Twilio Segment
Twilio Segment is a Customer Data Platform, which facilitates the aggregation of user data from different systems. We use Segment to better understand the touchpoints our customers have across the Springer Nature landscape and facilitate more personalized marketing, including support for eCommerce-related use cases such as improving user experience and engagement with shopping activities. The personal data shared with Twilio is for the most part based on consent and in other cases legitimate interest, Article 6 sec. 1 sent. 1 lit. a and f GDPR. For more information on how Twilio Segment processes personal data, see their privacy policy here.
Permutive
This Website uses services provided by Permutive Ltd., 1 Granary Square, London N1C 4AA, United Kingdom (“Permutive”) to support personalized advertising and content delivery. Permutive collects and processes pseudonymised data about user browsing behavior on our website in real time. This data is used to segment users into interest-based groups or “topics,” and to track engagement with eCommerce features such as product views and shopping activity. These insights enable us to deliver more relevant internal advertisements and content tailored to user preferences and shopping intent.
Permutive operates using first-party technology, which means data is processed directly within the user's browser without being shared externally. The segmentation and targeting are based on pseudonymised identifiers and do not involve direct identification of individuals.
The processing of personal data by Permutive is based on your consent, in accordance with Article 6 sec. 1 sent. 1 lit. a GDPR. You can manage your preferences at any time via the “Your Privacy Choices/Manage cookies” link in the page footer.
Targeted online advertising using email address and third-party advertising platforms
With your consent, we may occasionally run online advertising activities targeting you specifically by utilising personal information you have shared with us, namely your email address. This allows us to advertise in the most relevant way, promoting products, services and opportunities that we deem beneficial to you.
The legal basis for this processing is Article 6 sec. 1 sent. 1 lit. a GDPR, consent to the use of your email address for this purpose, including its transfer to third party advertising platforms.
This targeting method may be used on the following third-party advertising platforms: Meta, Google, LinkedIn, ResearchGate, Microsoft ads and Criteo.
Your personal data may be transferred outside of the EU to countries with varying data protection regulations.
To enable this, your personal data is shared in an encrypted form (hashed data). This means that you can only be identified by these companies if you have previously registered with them, adhering to their data processing terms and conditions. If you haven’t, your personal data will remain encrypted, protecting you from any identification thus not allowing this type of targeting method. In the same way, only personal data already shared with these platforms will be matched.
Depending on the platform, ads can be served on social media feeds, on third party websites/mobile applications or as sponsored links on search engines results pages. If you no longer wish your personal data to be used in this manner, you can email [email protected], and request that your consent be removed.
Equally, you can stop emails by clicking the unsubscribe link at the bottom of any email you receive. Related digital advertising can also be stopped directly via the third-party platform.
Salesforce
Throughout this website we use Salesforce to collect and process your personal data via forms. In these cases, the data you provide will only be used for the purpose of collection, for example, to contact you about the service or product of interest. We will not use the data for anything unrelated to this request. Salesforce act as a data processor on our behalf and we have a data processing agreement in place to support this arrangement. For more information on how Salesforce processes personal data see their privacy policy here.
Braze
We use Braze, customer engagement platform, to deliver personalized communications such as emails and on-site communication and improve communication relevance. Braze processes user data on our behalf to help tailor content based on user interactions and preferences. All data is handled securely and in accordance with applicable data protection laws; Braze acts as a data processor and does not use Springer Nature controlled data for its own purposes. See Braze’s privacy policyhere.
VIII. Analytics
Our Consent Management Platform
On this website we use a Consent Management Platform ("CMP") developed by Springer Nature to provide information about the cookies and other tracking technology used on our website and to manage user preferences on that behalf.
Our CMP places the following cookie on your computer:
sncc
This allows us to identify if the cookie banner is displayed, which choices you made and how to act upon those choices (Opt-in or Opt-out of cookie categories). This cookie is necessary for the website to function and cannot be switched off in our systems. This is usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences. Please [click here to review your current settings]. These cookies do not store any personally identifiable information.
You can set your browser to block these cookies, but some parts of the site may then not perform as designed.
Our CMP will also automatically collect additional information about you which will contain personal data only in limited cases and which is automatically recognised by our server (as per Section III, above). It is used to collect broad demographic information based on your IP address for anonymised, aggregated use. The legal basis for this processing is our legitimate interest in optimising our service by monitoring the effectiveness of our CMP, Article 6 sec. 1 sent. 1 lit. f GDPR.
For statistical analyses we use web analytics services such as Google Analytics, collect information about the use of this site.
General tracking information
The tools collect information such as:
- Device and browser information (operating system information, Mobile device identifier, mobile operating system, etc.)
- IP address
- Page accessed, URL click stream (the chronological order of our internet sites you visited)
- Geographic location
- Time of visit
- Referring site, application, or service
- Information about video content that you viewed
We use the information we get from the providers to determine the most useful information you are looking for, and to improve and optimise this website.
We will track your behaviour online for the purposes described above; this data will not be shared outside of Springer Nature. You can stop this tracking here.
The legal basis for this processing via Google Analytics is consent, Art. 6 sec. 1 sent. 1 lit.a GDPR, to analyse our website's traffic, improve the user's experience and optimise the website in general.
We do not share information on your web behaviour with any 3rd party providers without your explicit consent. Consent is provided by clicking the appropriate button on the web banner that appears on your first visit to the website. The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. a GDPR and represents you consent to accepting personalised advertisement cookies.
Depending on the provider the information generated about your use of the website may be transferred to and processed in third countries, e.g. the United States. For further information about the potential risks of a cross border data transfer please refer to section XI. The tools collect only the IP address assigned to you on the date you visit this site, rather than your name or any other identifying information. The provider will use this information in order to evaluate your use of the website, to compile reports on website activities and to provide other services relating to website and internet use to us.
Google Analytics
We use Google Analytics, a web analytics service provided by Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland ("Google"). The cookie set by Google Analytics on your device causes your web browser to transmit corresponding information to Google each time our website is called up. For example, Google Analytics collects data about the website from which a data subject has accessed a website (so-called referrer URL), which subpages of the website have been accessed or how often and for how long a subpage has been viewed. On our behalf Google will use the information generated by the cookie for the purpose of evaluating your use of the website, compiling reports on website activity and providing other services relating to website activity and internet activity in connection with the use of the website and according to your consent preferences.
The processing affects the following data categories:
- IP addresses
- Online identifiers (including cookie identifiers)
- Device identifiers
- Technical characteristics of users (e.g., browser type and version, device type, operating system)
- Measurement of user behavior (e.g., views of individual pages / content, views of content from different areas, session duration / dwell time, bounce rate
- Use of individual website functionalities (e.g. timetable information, search queries, downloads)
- Referral URL
We use the addition "_gat._anonymizeIp" for web analysis via Google Analytics. By means of this add-on, your IP address is shortened and anonymized by Google before transmission to the USA if our website is accessed from a member state of the European Union or the European Economic Area. Only in exceptional cases will the full IP address be transmitted to a Google server in the USA and shortened there.
The legal basis for the data transfer is Art. 28 GDPR in conjunction with the data processing agreement. The transfer of your personal data is subject to your consent according to Article 6 sec. 1 sent. 1 lit. a GDPR. You can consent to the processing of your data by Google Analytics using our Consent Manager, prevent the collection of your data or revoke consent once given. For revocation, call up the cookie settings again at the bottom of our website.
The information processed by Google about your use of this website may be transmitted to a Google server outside the EEA and processed there. The cross-border transfer is safeguarded by the Standard Contractual Clauses 2021. Your personal data will be anonymized by Google 14 months after your last activity, unless there is a legal obligation to retain it.
You may refuse the use of cookies by selecting the appropriate settings on your browser or by amending your preferences. In addition to that you may prevent the collection of the information generated by the cookie about your use of the website (including you IP address) and the processing of this data by Google if you download and install the browser plug-in available at the following link: http://tools.google.com/dlpage/gaoptout. You can access the Google Analytics privacy policy here.
SpeedCurve
We use SpeedCurve, a performance monitoring tool to identify, analyse and help fix website performance issues. SpeedCurve will process your personal data on our behalf, including your IP address. We have a data processing agreement in place to support this arrangement. The legal basis for this processing is Art. 6 sec. 1 sent. 1 lit. a GDPR and reflects your consent to non-essential performance measuring cookies. You can update or withdraw your consent by clicking Your privacy choices/Manage cookies in the page footer.
IX. Third party content and social media plug-ins
This website may contain links to third party websites. We are not responsible for the content and the data collection on respective third party websites; please check the privacy policy of respective websites for information of respective websites' data processing activities.
1. Social media plug-ins
We use the following social media plug-ins: Facebook, X. This allows you to communicate with such services and like or comment from our website. Social media plug-ins enable a direct communication between your device and the servers of the social media provider, allowing the social media provider to communicate with you and collect information about you browsing our website. This processing is based on Article 6 sec. 1 sent. 1 lit. f GDPR and represents our legitimate interest to improve your website experience and to optimise our services.
Further information about the processing of your personal data in the provider's course of operation is provided via their respective privacy policy. Moreover, you will be provided with further information with regard to your rights and setting concerning privacy.
a) Facebook Social Plugins
We use so-called social plugins ("plugins") of the social networking site facebook.com a service of Meta Platforms Inc, 1 Hacker Way Menlo Park, California 94025, USA ("Meta"). The plugins can be identified by one of Facebook's logos (white "f" on blue tile or a "thumps-up"-sign) or by the additional text "Facebook Social Plugin". The list of Facebook Social Plugins and their appearance can be accessed via: http://developers.facebook.com/plugins.
If a user visits one of the websites using such a plugin, the user's browser directly connects to Facebook's servers. The plugin and its content are made available directly on Facebook's servers and included in the website by the user's browser.
Due to the integration of the plugin Facebook collects the information that a user is visiting the corresponding website. If the user is logged in on Facebook at the moment he or she visits the website, Facebook may be able to connect the visit on the website to the user's Facebook account. If the user interacts with the plugin – for example if he or she presses the like button or comments on something – the user's browser transmits this information to Facebook. Facebook stores this information. If a user is not a member of Facebook, Facebook may collect and store the user's IP-address. Facebook states that it only collects anonymized IP-addresses in Germany.
The reason for and scope of the data acquisition and information about the way in which the data is processed and used by Facebook, as well as the user's rights in this respect and settings options for protecting the users privacy can be found under: https://www.facebook.com/policy.php.
If the user is a member of Facebook and does not wish Facebook to collect personal data via this homepage and to link this with his data stored on Facebook, the user needs to log off from Facebook before going to this homepage.
The user may also block Facebook's plugins using add-ons for the user's browser, for example the "Facebook Blocker".
b) X
We use the X-button. The button is provided by X Inc., 795 Folsom St., Suite 600, San Francisco, CA 94107, USA. ("X") The buttons are marked using the text "X" or "Follow" and a stylized blue bird. The button enables the user to share an article or a website of this homepage on X or to follow the provider on X.
If a user visits one of the websites using such a button, the user's browser directly connects to X's servers. The X-button and its content are loaded directly from X's servers and included in the website by the user's browser. According to the provider's knowledge, X collects the user IP-address and the website's URL when the button is loaded from X's servers. However, this data is only be used for loading and displaying the X-button.
Further information can be found in X's privacy statement under: https://x.com/en/privacy.
Should you have any questions regarding our privacy policy, please contact us via the email address [email protected].
X. Information sharing
Where personal data is disclosed to third parties for the purposes mentioned above the legal basis for the transfer of your personal data is Article 6 sec. 1 sent. 1 lit. b and f GDPR. Some of the recipients may reside outside the EEA. For further information about cross border transfer in general and transfers outside of the EEA see section on Cross border data transfers.
We may disclose your personal data to contractors/data processors who assist us in providing the services we offer through the website. Such a transfer will be based on data processing agreements (Art. 28 GDPR). Therefore, our contractors will only use your personal data to the extent necessary to perform their functions and will be contractually bound to process your personal data only on our behalf and in compliance with our requests.
In the event that we undergo re-organisation or are sold to a third party, any personal data we hold about you may be transferred to that re-organised entity or third party in compliance with applicable law.
We may disclose your personal data if legally entitled or required to do so (for example if required by law or by a court order). The legal basis for this will be Article 6 sec. 1 sent. 1 lit. c GDPR (in conjunction with the respective national law).
1.Peer Review and Author Services
In the course of providing our peer review services, your data may be accessed by different members of the editorial team such as editors and assistant to the editorial office. To determine the locations of the Editorial board members, you may refer to a journal’s homepage. Granting access to your personal data and the respective processing activity will be based on our and the legitimate interest of the respective society publishing the Journal in successfully publishing high quality articles and papers and ensuring the quality and significance of the respective research published in our journals, products and databases, Article 6 sec. 1 sent. 1 lit. f GDPR. In order to do so we and/or the respective society may process your personal data to find, contact and evaluate suitable and qualified peer reviewers within the relevant research community.
This also includes data sharing between us and the respective society. For example, we may share reviewer and author data to publish the journal.
Please note that the society and we are independently responsible for the respective data processing conducted. We neither have the control of the extent to which personal data is processed by the respective society nor do we control the processing purpose or the period your personal data will be retained. It is also possible that the above-mentioned societies may disclose your personal data to their business partners, third parties or authorities. For further information on the data processing under the society’s control please refer to the respective society’s privacy notice.
We provide TOC (table of content) alerts to members as part of the services they are entitled to under their membership with the society. This is a core element of the overall service and to this end your personal (i.e. name and email address) data is transferred to Springer Nature by the society. The legal basis for processing is Art. 6 (1) 1 lit. b GDPR. Individual members may opt-out of TOC alerts at any time via our support portal or using the unsubscribe link in every email. This applies equally to Book Series Partners, in the event that book volume alerts are sent to a Series Partner's registered recipients.
Your personal data will be transferred to and processed inside and outside of the EEA. For further information on cross border data transfer, please refer to section on Cross border data transfers.
As an author we’ll share your personal data with third parties, like your institution or employer. This is required to manage and approve payment of associated Article Publication Charges (APCs) in order to fulfill the publication of your manuscript. The legal basis is Art. 6 (1) 1 lit. b GDPR.
By submitting your article for consideration, you acknowledge that if you are recognised as affiliated to an institution or funder with a Springer Nature open access agreement, your name and contact details may be shared with a representative from that institution or funder in order for us to verify whether they agree to cover, in full or in part, the article processing charge (APC) that is payable upon editorial acceptance of submitted articles. For this, the legal basis is Article 6 sec. 1 sent. 1 lit. b GDPR, to fulfil our contractual obligations to you.
Should you choose not to follow the open access route to publication we may still share your personal data with the institution or funder you're affiliated with. Importantly we will only do this post publication to ensure there's no bearing on the evaluation of your submission prior to acceptance. The legal basis to share your data in this instance is Article 6 sec. 1 sent. 1 lit. f GDPR, our legitimate interest to develop and improve our open access program to the benefit of authors and the scientific community generally.
Customer service, administrative, operational and systems support is provided by other entities of the Springer Nature Group and third party contractors (together "Contractors"). We may disclose your personal data to Contractors who assist us in providing the services we offer through the Submission and Peer Review System. Such a transfer will be based on data processing agreements in accordance with Article 28 of the GDPR. Therefore, our Contractors will only use your personal data to the extent necessary to perform their functions and will be contractually bound to process your personal data only on our behalf and in compliance with our requests. Further services, provided by third party technology and service providers, are similarly bound by data processing agreements.
2. Usage Reports
We may disclose anonymous aggregate statistics about users of the website in order to describe our services to prospective partners, advertisers and other reputable third parties and for other lawful purposes, but these statistics will include no personal data. We also supply standardized usage reports to institutional customers, also known as Counter Reports. For more information on Counter Reports - https://www.projectcounter.org/code-of-practice-sections/usage-reports/
In addition to the above mentioned anonymous reports and by special arrangement:
When you read research journals and eBooks or use database products, we will process your personal data to create usage reports. For journals and eBooks this will include your full text HTML and PDF downloads, your IP address and potentially your email address. This data is necessary for the usage report as it provides information on the usage and overall interest in a particular journal or group of journals or eBooks.
The legal basis is Art. 6 (1) 1 lit. f GDPR. We have a legitimate interest to assess and evaluate the use of our content to be able to improve our services. We will retain this data securely for ongoing internal analysis and future reference.
We may share the usage data with licensee under whose license you are accessing and using our services, (e.g. your employer, the institution you are a member to, your university etc. "Licensee"). The legal basis is Art. 6 (1) 1 lit. f GDPR. The Licensee has a legitimate interest in using the usage data to assess and evaluate the economic efficiency of its license for our content. Based on this evaluation, the Licensee will be able to determine e.g. the necessity to obtain more licenses or reduce the number of licenses or to allocate costs internally. Further, the usage data may allow the Licensee to request contributions or funding. The Licensee is contractually limited to use using the usage data for no other purposes than these economic efficiency assessment purposes.
In addition, we ourselves have a legitimate interest in enabling the Licensee to use the usage data to conduct respective evaluation and assessments is also in our interest as it makes our service more attractive for the Licensees.
If the Licensee resides outside the EEA, the transfer is safeguarded by a Commission's adequacy decision or EU Standard Contractual Clauses. You can find further information about the aforementioned safeguards by contacting [email protected].
You may object to the transfer of the usage data to the Licensee at any time without reason by sending an email to [email protected].
XI. Cross border data transfers
Within the scope of our information sharing activities set out above, your personal data may be transferred to other countries (including countries outside the EEA) which may have different data protection standards from your country of residence. Please note that data processed in a foreign country may be subject to foreign laws and accessible to foreign governments, courts, law enforcement, and regulatory agencies. However, we will endeavour to take reasonable measures to maintain an adequate level of data protection when sharing your personal data with such countries.
In the case of a transfer outside of the EEA, this transfer is safeguarded by the EU Model Clauses in accordance with Article 46 GDPR. You can find further information about the aforementioned safeguards by following this link https://ec.europa.eu/info/law/law-topic/data-protection_en or contact our Group Data Protection Officer via our support portal.
XII. Security
We have reasonable state of the art security measures in place to protect against the loss, misuse and alteration of personal data under our control. For example, our security and privacy policies are periodically reviewed and enhanced as necessary and only authorised personnel have access to personal data. Whilst we cannot ensure or guarantee that loss, misuse or alteration of information will never occur, we use all reasonable efforts to prevent it.
You should bear in mind that submission of information over the internet is never entirely secure. We cannot guarantee the security of information you submit via our website whilst it is in transit over the internet and any such submission is at your own risk.
XIII. Data retention
We strive to keep our processing activities with respect to your personal data as limited as possible. In the absence of specific retention periods set out in this policy, your personal data will be retained only for as long as we need it to fulfil the purpose for which we have collected it and, if applicable, as long as required by statutory retention requirements.
XIV. Your rights
Under the legislation applicable to you, you may be entitled to exercise some or all of the following rights:
- require (i) information as to whether your personal data is retained and (ii) access to and/or duplicates of your personal data retained, including the purposes of the processing, the categories of personal data concerned, and the data recipients as well as potential retention periods;
- request rectification, removal or restriction of your personal data, e.g. because (i) it is incomplete or inaccurate, (ii) it is no longer needed for the purposes for which it was collected, or (iii) the consent on which the processing was based has been withdrawn;
- refuse to provide and – without impact to data processing activities that have taken place before such withdrawal – withdraw your consent to processing of your personal data at any time;
- object, on grounds relating to your particular situation, that your personal data shall be subject to a processing. In this case, please provide us with information about your particular situation. After the assessment of the facts presented by you we will either stop processing your personal data or present you our compelling legitimate grounds for an ongoing processing;
- take legal actions in relation to any potential breach of your rights regarding the processing of your personal data, as well as to lodge complaints before the competent data protection regulators;
- require (i) to receive the personal data concerning you, which you have provided to us, in a structured, commonly used and machine-readable format and (ii) to transmit those data to another controller without hindrance from our side; where technically feasible you shall have the right to have the personal data transmitted directly from us to another controller; and/or
- not to be subject to any automated decision making, including profiling (automatic decisions based on data processing by automatic means, for the purpose of assessing several personal aspects) which produce legal effects on you or affects you with similar significance.
You may (i) exercise the rights referred to above or (ii) pose any questions or (iii) make any complaints regarding our data processing by contacting us using the contact details set out below.
XIV. Contacting us
Please submit any questions, concerns or comments you have about this privacy policy or any requests concerning your personal data by email to our Group Data Protection Officer. You can contact our Group Data Protection Officer via our support portal.
The information you provide when contacting us via our support portal will be processed to handle your request and will be erased when your request is completed. Alternatively, we will restrict the processing of the respective information in accordance with statutory retention requirements.
XV. Amendments to this policy
We reserve the right to change this policy from time to time by updating our website respectively. Please visit the website regularly and check our respective current privacy policy. This policy was last updated on 21st May 2026.
Get your manuscript ready for journal editors
Figures and tables
Avoid submission delays by ensuring that all your figures, tables and illustrations are annotated in line with the journal submission guidelines.
Legends and numbering must be consistent with any mentions in the text.
A well-designed table should have:
- Clear and concise legends and captions.
- Sufficient spacing between columns and rows.
- Clear units.
- Font type and size are legible.
Key facts:
Poorly presented tables and figures, missing legends and citations in the text, will cause your manuscript to be delayed and sent back to you for amendments.## Essential reading
More help
The Springer Nature Figure Formatting service can help you to improve the quality of your figures and tables and ensure they conform to your chosen journal's specifications.
Follow the journal submission guidelines to increase your chances of success.
We recommend you read the guidelines as soon as you have chosen your target journal.
Write your manuscript according to the guidelines and ensure you include everything editors will expect to see.
Use the guidelines to find out about:
- Word and character limits (title, running title, abstract, manuscript text)
- What sections to include
- Formatting requirements
- References
- Editorial policies
- File formats
- Funding
Publication and funding
There are two publishing options, depending on the type of journal you choose.
Open access
If you want your research to be freely available to everyone immediately on publication, or your funder or institution requires this, then you should choose a journal that offers open access. If you select this method, you or your funders will be responsible for paying an article processing charge (APC).
To find out more about funder and institutional open access requirements and getting help with APCs see our Guide to open access funding.
Subscription
Under this model, the cost of publishing is covered through journal subscription fees and you won’t need to pay an APC. Your research will only be seen by those subscribing to the journal.